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SUMMARY
Obesity often predisposes to coronary heart disease, heart failure, and 
sudden death. Also, several studies suggest a reciprocal enhancing interaction 
between obesity and sleep curtailment. Aim of the present study was to go deeper 
in the understanding of sleep and cardiovascular regulation in an animal model of 
diet-induced obesity (DIO). According to this, Wake-Sleep (W-S) regulation, and 
W-S dependent regulation of cardiovascular and metabolic/thermoregulatory 
function was studied in DIO rats under normal laboratory conditions and during 
either wake or sleep enhancement, during sleep deprivation and in the following 
recovery period, respectively. 
After 8 months of the delivery of a hypercaloric (HC) diet, treated animals 
were heavier than those fed a normocaloric (NC) diet (NC: 441 ±17g; HC: 
557±17g). HC rats slept more than NC ones during the activity period (Dark) of 
the normal 12h:12h light-dark (LD) cycle (Wake: 67.3±1.2% and 57.2 ±1.6%; 
NREM sleep (NREMS): 26.8±1.0% and 34.0±1.4%; REM sleep (REMS): 5.7±0. 
6% and  8.6±0.7%; for NC and HC, respectively; p<0.05 for all). HC rats were 
hypertensive throughout the W-S states, as shown by the mean arterial blood 
pressure values across the 24-h period (Wake: 90.0±5.3 and 97.3±1.3; NREM: 
85.1±5.5 and 92.2±1.2; REM: 87.2±4.5 and 96.5±1.1, mmHg for NC and HC, 
respectively; p<0.05 for all). Also, HC rats appeared to be slightly bradycardic 
compared to NC ones (Wake: 359.8±9.3 and 352.4±7.7; NREM: 332.5±10.1 and 
328.9±5.4; REM: 338.5±9.3 and 334.4±5.8; bpm for NC and HC, respectively; 
p<0.05 for Wake). In HC animals, sleep regulation was not apparently altered 
during the sleep rebound observed in the recovery period following sleep 
deprivation, although REMS rebound appeared to be quicker in NC animals. 
In conclusion, these data indicate that obesity interferes with W-S and 
cardiovascular regulation and that DIO rats as a suitable model to be used for a 
better understanding of obesity comorbidities.  
12
13
EXTENDED SUMMARY
Introduction. The prevalence of obesity has risen dramatically worldwide. 
Obesity represents one of the most serious public health challenges since it tends 
to cluster with hypertension, insulin resistance, and dyslipidemia, which are 
documented risk factors for coronary heart disease and heart failure. In particular, 
in obese humans, arterial blood pressure (BP) is higher than in lean controls and 
decreases less than in lean controls on passing from the diurnal activity period to 
the nocturnal rest period. The consequences of these alterations on cardiovascular 
function still have to be fully clarified. In humans and animal models, the 
development of obesity is associated with alterations in the Wake-Sleep (WS) 
structure. In obese humans, excessive daytime sleepiness is associated with poor 
quality of sleep at night, partly because of the occurrence of sleep apneas which 
disrupts sleep. The tight link between sleep and obesity has also been stressed by 
recent data showing that sleep curtailment and sleep disturbances would lead to 
weight gain and to the development of insulin resistance and type-2 diabetes.
The circadian distribution and quality of W-S states are major 
determinants of the circadian arterial BP rhythm because they contribute to 
differences in BP between activity and rest periods. During non-Rapid Eye 
Movement sleep (NREMS), arterial BP decreases compared to Wake in humans 
and rodents, while during Rapid Eye Movement sleep (REMS), an apparent re-
patterning of sympathetic activity to cardiovascular effectors causes changes in 
arterial BP, the direction and magnitude of which are highly sensitive to genetic 
and pathological factors in different species.
In general, obesity and other metabolic syndrome traits in humans ensue 
from interactions between polygenic susceptibility and an obesogenic 
environment. The understanding of the mechanisms of these interactions can be 
therefore hastened by studying animal models of diet-induced obesity (DIO), 
which present critical features of obesity in humans. In particular, about 50% of 
Sprague-Dawley rats fed a hyperlipidic/hypercaloric (HC) diet develops obesity in 
few weeks with derangements of glucose metabolism and reduced glucose 
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tolerance, hypercholesterolemia, hypertriglyceridemia, hyperleptinemia, and 
hypoghrelinemia. However, it is still unclear whether DIO rats develop 
hypertension. The relationship between obesity and sleep has been studied in 
several rodent models of obesity. These models develop obesity following the 
administration of a HC diet or through genetic manipulations aimed at interfering 
with the leptinergic system.  All these studies showed the trend in obese animal to 
increase the amount of NREMS, while variable results have been seen on REMS 
and the daily distribution during L or D periods of the W-S states. However, no 
long-term studies on the effects of DIO on W-S and cardiovascular regulation 
have been carried out until now in the rat, which is currently the most widely used 
animal model in experimental biology.
The aim of this research was to study the structure of the W-S cycle and 
the possible state-dependent changes of brain temperature and cardiovascular 
function in rats made obese by the chronic administration of a HC diet. This 
experiment has also been conducted with the aim of identifying possible changes 
made by the prolonged administration of a HC diet to sleep regulation in response 
to a previous sleep deprivation. Particular care has been placed in the analysis of 
the possible modifications of the fine architecture of REMS, whose occurrence is 
strongly influenced by the degree of activation of thermoregulatory/metabolic 
processes and is under the control of central nervous structures at hypothalamic 
level that are known to be also involved in the regulation of body 
temperature/metabolism and food intake.
Methods. Male Sprague-Dawley rats were divided into two groups: a control 
group was fed a normocaloric (NC) diet while the other group was fed a 
hypercaloric (HC) diet (35% fat). Both groups were kept at an ambient 
temperature (Ta) of 25°C ± 0.5 °C, under a 12:12 h light-dark (LD) cycle, and had 
free access to food and water. At the 8th week form diet differentiation, 8 NC rats 
and 8 among the higher weight gained-rat from the HC group underwent surgery. 
Animals were deeply anaesthetized (diazepam, 5mg/kg, i.m., followed by 
ketamine-HCl, 100 mg/kg, i.p) and surgically implanted with: i) two epidural 
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electrodes for electroencephalographic (EEG) recording; ii) two electrodes for 
nuchal electromiographic (EMG) recording; iii) electrodes for the measurement of 
the diaphragmatic myoactivity. iv) a hypothalamic thermistor implanted above the 
left anterior hypothalamus for the determination of hypothalamic temperature 
(Thy); v) a catheter placed into the femoral artery for the telemetric recording of 
arterial BP and heart rate (HR).
Animals recovered from surgery for at least one week in a Plexiglas cage 
within a thermoregulated, sound-attenuated chamber where they were kept 
throughout the experiment. For both groups, recordings were carried out for four 
consecutive days: the first and second days were taken as the baseline (BL),
during the third day rats were sleep deprived (SD) by gentile handling along the 
entire 12-h L period and then they were allowed to recover for the entire 12-h D 
period of the third day (R0) and for the whole following day (fourth day, R1).
Sleep stages were scored offline according to standard criteria based on EEG, 
EMG and Thy signals. Particular care was placed in the detection and the 
separation of Single and Sequential REMS episodes, since this partition has been 
shown to be critical in describing the processes underlying REMS regulation. In 
particular, sequential REMS episodes are those separated by short time intervals 
(<= 3min) and occurring in rapid sequence, while single REMS episodes are those 
separated by long time intervals (> 3min). EEG power spectra analysis in the 
Delta (0.5-4.0 Hz), Theta (5.5-9.0) and Sigma (11.0-16.0 Hz) band for the 
different wake-sleep states was also carried out offline.
Results and conclusions. After 8 weeks of treatment the weight was higher in the 
HC group than in the NC group (HC, 557±17g; NC, 441±17g; p<0.05). Under BL 
conditions, the 24-h total sleep amount and the amount of both NREMS and 
REMS was significantly larger in the HC group compared to the NC one, 
although for REMS the statistical significance was not reached. The analysis 
carried out on a 12-h time scale showed that HC animals slept significantly more 
than the NC animals during the D period, leading to the disappearance of the 
normal LD distribution of REMS. The analysis of the partition in Single and 
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Sequential REMS showed that in both group the increase of REMS during the D 
hours was substantially due to a significant increase in Sequential REMS, 
confirming that REMS regulation is mostly made through the modulation of 
Sequential REMS. Major changes were also observed on a 24-h basis on
cardiovascular parameters. In particular, HC animals showed to be significantly 
hypertensive and bradycardic when compared to NC ones. In particular, mean 
arterial BP was significantly higher in each of the three W-S states in HC than in 
NC animals. No relevant changes were observed in average Thy levels.
The analysis of W-S parameters during the recovery period which 
followed sleep deprivation showed that the majority of the expected sleep rebound 
occurred during R0 in NC animals. This pattern was reproduced in the HC group. 
The analysis of the partition in Single and Sequential REMS clearly indicated that 
REMS rebound occurred under the form of Sequential REMS in both NC and HC 
animals. No substantial differences were observed in the dynamics of the 
accumulation of NREMS in the two groups, while that if REMS was slightly 
faster in the NC animals. Also, the dynamics of Delta Power, which is an index of 
the intensity of NREMS rebound, followed a similar pattern in NC and HC 
animals. An increase in arterial BP levels was observed during SD in the NC 
animals in both Wake and NREMS. These values returned to baseline levels in R0 
and even to levels lower than those of the baseline during R1 in each of the three 
W-S states Interestingly, this arterial blood pressure drop during R1 was not 
present in HC animals. On the contrary, heart rate fell in both groups during R1. 
Thus, it may be concluded that the results of the present experiment 
indicate that in the rat the development of obesity deeply interfere with both W-S 
and cardiovascular regulation and that diet-induced obesity rats represent a very 
good model for further studies aimed at going deeper in the understanding of the 
disturbances in the W-S activity and of the cardiovascular comorbidities which 
accompany the development of obesity in humans.
17
1. Introduction
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OBESITY AND OVERWEIGHT
Obesity is now so common within the world’s population that it is starting 
to replace undernutrition and infectious diseases as the most significant 
contributor to ill health. Either independently or in association with other diseases 
it causes or exacerbates many health problems, (Kopelman, 1994). The generally 
accepted view is that being overweight causes, to a lesser degree, similar health 
problems to obesity. 
Obesity and overweight are considered the most important risk factors 
beside high blood pressure, high concentrations of cholesterol in the blood, 
inadequate intake of fruit and vegetables, physical inactivity and tobacco use 
which cause what is known as noncommunicable diseases. The Build and Blood 
Pressure Study pointed out that the side effects of overweight tend to be delayed, 
sometimes longer than ten years (Society of Actuaries, 1980). Obesity is 
established well now as an independent risk factor for type 2 diabetes, 
dyslipidemia, and cardiovascular diseases (CVD) (Bastard et al., 2006). 
According to the World Health Organization (World Health Organization, WHO) 
in the data published in 2003 by the WHO as part of the "Global Strategy on Diet, 
Physical Activity and Health", the worldwide burden of noncommunicable 
diseases has rapidly increased. Noncommunicable diseases caused in 2001 almost 
60% of the 56 million deaths annually and 47% of the global burden of disease. 
On the light of these figures and the predicted growth of the figures in the future 
of disease burden which are expected to reach to 73% and 60%, respectively, by 
2020 a major challenge arises to the global public health in order to prevent this 
risk. Among the causative factors of the major noncommunicable Diseases, 
namely; cardiovascular disease, type 2 diabetes, coronary heart disease (CHD), an 
increased incidence of certain forms of cancer, respiratory complications 
(obstructive sleep apnoea, OSA) and osteoarthritis of large and small joints, 
unhealthy diets and physical inactivity are considered key determinants and 
principally contribute to the worldwide burden of disease, disability and death. It 
20
was noticed that in developing countries, and even in low-income groups in richer 
countries, the prevalence of overweight and obesity is increasing.
1.1.1 DEFINITION
The concept of body mass index (BMI, Body Mass Index, BMI = weight 
(kg) / height (m) squared high) which is used as a measure of the weight gain, was 
firstly introduced by the Belgian scientist Adolphe Quetelet (Eknoyan, 2008) in 
1832 until 1972. It is assumed that it took the present name from the suggestion of 
Ancel Keys. It allows meaningful comparisons of weight status within and 
between populations and the identification of individuals and groups at risk of 
morbidity and mortality.
1.1.2 OVERWEIGHT vs. OBESITY
On this basis, it is conventionally considered overweight individuals who 
have a BMI greater than 25 kg/m2 and obese those who have a BMI greater than 
30 kg/m2 but this does not take into account the morbidity and mortality 
associated with more modest degrees of overweight, nor the detrimental effect of 
intra-abdominal fat.  In the context of this work, obesity is considered 
synonymous with pathological weight gain. By this definition, Najjar et al. (1987) 
mentioned that over 50% of adults’ populations in the United States are 
overweight.
Obesity cases have tripled since 1980 in the WHO European basin which 
consist of 53 countries (WHO, 2007, 2009), (currently overweight varies in 
different countries of the WHO European region, between a minimum of around 
30% and maximum around 80% of the adult population, it is estimated that of 
these individuals, at least 30% is obese) and are continuing alarming increase in 
youth. The trend of overweight in the WHO European region has shown an 
average increase of 0.1 percentage points during the '70s, by 0.4 percentage points 
in the '80s, by 0.8 percentage points in the early 90s and, in some countries, by 2 
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percentage points in the year 2000. The Task Force on International Obesity 
predicts that about 38% of school-age children in the European region of WHO 
will be overweight by 2010 and that more than a quarter of them will be obese. 
This alarmed recall from WHO is justified by the expectation that individuals with 
overweight in childhood redirected much more easily to the adult obesity (Barker, 
2006; Venn et al., 2007).
The issue of overweight moved from the individual to the more purely 
social by the aid of the systematic approach to the problem. In fact, the use of 
sophisticated tools of analysis has led us to consider the association between 
overweight with other diseases not only as an expression of co-morbidity, but also 
as one of the major risk factors for the health of the population. Furthermore, the 
continuous refinement analysis allows now to follow not only the effects of 
changes in individual income, but also those of other health interventions. E.g. 
overweight is considered as an important risk factor not only in the developed 
regions, but also in the underdeveloped and, in particular, in those of the 
population that show a level of mortality which could be reduced mostly by the 
improvement of the state of general nutrition and treatment of infectious diseases 
(Ezzati et al., 2002).
In this context it should be emphasized the fact that the weight gain and, 
particularly, obesity, are characterized by a practically absolute co-morbidity with
diabetes type 2 and more relative, but still significant, with the type of
hypertensive cardiovascular disease and thrombus-embolic (same reference).
1.1.3 OBESITY AND LIFE EXPECTANCY
The International Bank for Reconstruction and Development (The World
Bank) in 1990 has further developed the index of life expectancy by introducing
the index DALY (disability-adjusted life years), also generically assignable to
each individual (The World Bank, 1993). It is a measure of overall disease 
burden, expressed as the number of years lost due to ill-health, disability or early 
death. On other words, the DALY is the sum of years of life lost to premature 
22
death or disability occurred due to illness or accident, the calculation of the index
requires you to weigh the degree of disability and to define the average duration 
of the disease.
The weight gain, pathological or less, represents a well defined risk factor 
as it is possible easily and accurately evaluates its distribution in a particular 
population. Overweight and obesity are the fifth risk factor for death worldwide
(the third in the middle and high-income countries) and the tenth in generating
DALY (the fourth in middle-income countries and the third in high-income 
countries). However, when you take into account the food intake as the 
fundamental cause of overweight and obesity are associated with this and other 
risk factors correlated to dietary imbalances (hypertension, hyperglycemia, 
reduced physical activity, hypercholesterolemia, low intake of fruits and 
vegetables), you reach a set which is the highest cause of death and generation of
DALYs. Fontaine et al.(2003) reported that even fifty years ago, overweight and 
especially obese men and women taking out insurance policies were known die 
earlier than the lean one. Other studies had mentioned that obesity shortens life 
expectancy by 7 years at the age of 40 years (Peeters et al., 2003). The positive 
relation between the increase in BMI and the increase in risk of death declines 
progressively with age but remains substantial until the age-group of 75 years 
(Stevens et al., 1998). Thus, the UK government now estimates that English man 
with BMI of 25·0 kg/m2 has less life expectancy by 2 years and the expected 
value would reach 5 years by 2050 (Haslam and James , 2005). In USA, each 
year, an estimated 300,000 US adults die of causes related to obesity (Allison et 
al., 1999). The rapid growth in the number of overweight and obese individuals
found in the world has been defined by WHO as epidemic (obesity Epidemics), a 
term introduced in 1999 in an analysis regarding the dissemination of overweight
in the United States from 1991 to 1998 (Mokdad et al., 1999). 
In this context, this consideration of the obesity and overweight as disease 
cases create an opinion that the treatment of the obesity and overweight could be 
covered by the health insurance.
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The movement in this direction was implemented in a country with high 
economic development such as the USA and was indirectly imprinted by the
simultaneous discovery, by two different research groups, the existence of a 
peptides neurotransmitter (De Lecea et al., 1998) exclusively localized in neurons
of the lateral hypothalamus (Peyron et al., 1998) and acting on the control of food 
intake (Sakurai et al., 1998). These neuropeptides, hypocretin (HCRT) 1 and 2,  
also called orexin 1 and 2 appointed that the main effect was obtained following 
its administration, which was to increase food intake. Few years after their 
discovery, it was shown that HCRT neurons degenerate in patients suffering from 
Narcolepsy (Peyron et al., 2000) Narcolepsy with cataplexy (NC) is an 
hypersomnia of central origin characterized by loss of clear boundaries between 
sleep and wakefulness leading to severe sleepiness. NC patients can quickly enter 
in REM sleep at any time of the day and also experience REM sleep like episodes 
intruding into wakefulness, such as loss of muscle tone triggered by emotions 
while awake (cataplexy). This suggest the existence of a strong link in  the neural 
processes underlying wake-sleep regulation and the regulation of food-intake 
(Sakurai et al., 2011).
1.1.4. HUMORAL FACTORS INVOLVED IN THE INTERACTION 
BETWEEN OBESITY AND CARDIOVASCULAR  (DYS) FUNCTION 
There is now clear evidence that for a given adiposity, a large 
heterogeneity in the metabolic and cardiovascular risk mainly linked to the 
distribution and position of excessive adipose tissue. While central or visceral 
accumulation of fat is an important predictive factor of lipid, glucose or 
atherogenic disturbances, the peripheral one is not associated with increased 
alterations at the metabolic level.
A special attention should be paid to the relationship between fat cells and 
the immune system due to the strikingly and strong discovery which pointed out 
the association between obesity with a low-grade inflammation process in adipose 
tissue. In animal models (rodents), obesity is associated with a chronic 
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inflammatory reaction, which characterized by activation of some pro-
inflammatory signaling pathways and abnormal adipokine production which in 
turn result in occurrence of a cascade of several biological markers of 
inflammation (Bastard et al., 2002). Nowadays, any protein that can be 
synthesized and secreted by adipocytes can be given the name adipokine 
(Trayhurn and Wood, 2004).  In contrary, these biological parameters are 
diminished or at least normalized by the loss of BMI. Several animal models 
supported the idea of a causal relationship between these inflammatory processes 
with obesity and its co-morbidities such as insulin resistance, type-2 diabetes and 
CVD. 
Leptin, is the product of the ob gene. It is involvement in regulation of 
energy homeostasis is documented by several authors e.g. (Zhang et al., 1994). It 
is almost exclusively expressed and produced by white adipose tissue (WAT), in 
particular, mature adipocytes. In obesity, the circulating levels and adipose tissue 
mRNA expression of leptin show significant correlation with BMI and fat mass. 
There is a relationship between leptin and the low-grade inflammatory state in 
obesity despite the fact that the main action centre of leptin is at the central 
nervous system (CNS) in regulate food intake and energy expenditure which 
created a suggestion that leptin could have peripheral biological effects due to its 
cytokine-like structure. Leptin is caopable to regulate tumor necrosis factor-α 
(TNF-α) production and activation by macrophages (Loffreda et al., 1998)
TNF-α is a pro-inflammatory cytokine produced mainly by lymphocytes 
and macrophages however, a variety of cell-types could produce it also. Adipose 
tissue can produce TNF-α although in human, this production is weak. It is 
thought that TNF-α plays a major role in the pathophysiology of insulin resistance 
in rodents via the phosphorylation of the insulin receptor substrate-1 (IRS-1) 
protein on serine residues (Hotamisligil et al., 1993). Moreover, plasma TNFa 
concentrations are significantly elevated in obese animals, and its level is 
positively correlated with insulin resistance and massive obesity.
Interleukin-6 is multifunctional cytokine acting on many cells and tissues. 
IL-6 is produced by many cell types (fibroblasts, endothelial cells, monocytes) in 
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addition to other tissues including fat tissue. It is now well established the 
increment of IL-6 production by adipose tissue in obesity (Bastard et al., 2002). 
Ali et al. (1997) mentioned that in the absence of an acute inflammation, a 
percentage of 15 to 30 % of circulating IL-6 levels derives from adipose tissue. 
Furthermore, at the level of the central nervous system, it may induce energy 
expenditure (including thermogenesis) and inhibit feeding behaviour (Wallenius 
et al., 2002). One of the main effects of IL-6 is the induction of hepatic C-reactive 
protein (CRP) production and the strong relation between IL-6 levels in adipose 
tissue with the circulating IL-6 and CRP is well established now (Ridker , 2003). 
In addition, IL-6 has been recently proposed to play a central role in the link 
between obesity, inflammation and coronary heart diseases (Yudkin et al., 2000).
However the mechanism is a matter of debate, it has now been clearly 
demonstrated that cytokines such as TNF-α and IL-6 are capable to inhibit insulin 
action (Rieusset et al., 2004). Therefore, the chronic increase in circulating 
cytokine levels could contribute to insulin resistance in addition to the aggravation 
of the cardiovascular risk linked to inflammation.
Also, IL-6 and TNFa were highest in the sleep apnea group, which had the 
highest BMI among the patient groups studied. Interestingly, even in the absence 
of sleep apnea, obesity is more frequently associated with subjective complaints 
of fatigue, EDS and nocturnal sleep disturbance. The results obtained by Vgontzas 
et al. (1997) presented that inflammatory cytokines especially, IL-6, might be 
related with the enhancement of fatigue and sleepiness exhibited by obese 
subjects.
In recent studies in animals and human models, the positive regulation of 
IL-6 production was found to be via catecholamines through beta adrenergic 
receptors (DeRijk et al., 1994; Papanicolaou et al., 1996).  Stimulation of  
peripheral sympathetic activity in sleep apnea and obesity is known (Landsberg, 
1999). Furthermore, circulating IL-6 stimulates the hypothalamic–pituitary–
adrenal (HPA) axis, and this stimulation is associated with this activation of 
which is associated with hypertension, central obesity and insulin resistance. F
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An important role of insulin in the relationship between dietary intake and 
sympathetic nervous system (SNS) activity was reported previously. Insulin 
mediates glucose uptake in central hypothalamic neurones responsible about the 
SNS activity in response to dietary intake, this links the hyperinsulinemia of 
obesity to sympathetic stimulation, the latter exerting a prohypertensive effect 
mediated by the kidney, the heart, and the vasculature.
The glucose uptake from neurons of ventromedial hypothalamus is 
decreased during fasting due to small fall in glucose and the larger fall in insulin. 
This decrease in glucose metabolism suppresses the sympathetic output by an 
inhibitory pathway between the hypothalamus and brainstem sympathetic centers. 
In contrast, the small increase in glucose and the greater rise in insulin, either in 
the presence of insulin resistance or increased carbohydrate intake, facilitates 
insulin-mediated glucose metabolism in these hypothalamic neurons, which leads 
to suppression of the inhibitory pathway and disinhibition of chronically active 
brainstem sympathetic centers and the result is increment in sympathetic outflow 
(Landsberg, 1999).
1.2 THE WAKE-SLEEP CYCLE
1.2.1 DEFINITION
Sleep is usually defined by sustained quiescence in a species-specific 
posture whereas the responsiveness to external stimuli is reduced, but the 
definition regarding mammals sleep requires several additional criteria, such as 
characteristic changes in electroencephalogram (EEG) and reversibility to wakeful 
state which distinguish sleep from coma and hypothermic states e.g. hibernation 
(Zepelin et al., 2005).
In the Wake-Sleep cycle (W-S cycle), these two states namely; wake and 
sleep are considered a consecutive behevioral states that are defined precisely by 
the recording of electrical potentials produced by the cerebral cortex EEG, the 
extrinsic muscles of the eye (electrooculogram, EOG) and skeletal muscle
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(electromyogram , EMG). The WS cycle is constituted of the wake state in 
addition to two basic sleep states namely; rapid eye movement sleep (REMS) and
non-REM sleep (NREMS).
1.2.2 WAKE AND WAKE ACTIVATING SYSTEM
In the early 1900, many physiologists believed that wakefulness and 
consciousness were maintained by ongoing sensory inputs to the brain. In 1940 
Moruzzi and Magoun suggested that the disappearance of waking parameters is 
due to the interruption of input of the brainstem’s netlike core of neurons, the 
reticular formation. They showed also that electrical stimulation of the reticular 
formation, but not the sensory pathways, initiated a long lasting and widespread 
activation of the cortex accompanied by substitution of the cortical slow waves 
with fast activity (Moruzzi and Magoun, 1949). Moreover, the lesions induced in 
the reticular formation, but not the sensory pathways, produced a loss of cortical 
activation which replaced by cortical slow waves and an immobility state 
resembled coma. The locations of the most marked lesions were in the oral 
pontine, midbrain reticular formation, posterior hypothalamus and subthalamus 
where ascending pathways reach into the forebrain. According to the 
electrophysiological and neuroanatomical studies, collateral input from, somatic, 
visceral and special sensory systems is received by the reticular formation to be 
projected in turn dorsally to the thalamus or ventrally to the basal forebrain. The 
impulses are then re-projected from thalamus and forebrain to be relayed in 
widespread manner to the cerebral cortex. This system called the ascending 
reticular activating system and is considered necessary and sufficient for the 
behavioral arousal of wakefulness and tonic maintenance of the cortical 
activation. 
The origin of the ascending arousal system is largely from a series of well-
defined cell groups with known neurotransmitters (Saper et al., 2001). This 
pathway has two major branches: the first ascending pathway branch to the 
thalamus activating the crucial part for the transmission of information to the 
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cortex, namely thalamic relay. The pedunculo-pontine and laterodorsal tegmental 
nuclei (PPT/LDT) (Hallanger et al., 1987), a pair of acetylcholine-producing cell 
groups is considered as the major upper brainstem source of input to the thalamic 
relay as well as the thalamic reticular nucleus. During the cortical activation i.e. 
during Wake and REMS states, PPT/LDT neurones fires most rapidly. In contrast, 
during NREMS, these neurones are much less active. As the reticular nucleus is 
positioned between the thalamic-relay nuclei and the cerebral cortex, their input is 
believed as gating mechanism capable to block transmission between thalamus 
and cortex which is important for wakefulness McCormick, 1989). The second 
branch of the ascending arousal system activates neurons in the lateral 
hypothalamic area and basal forebrain and throughout the cerebral cortex (Jones,
2003). The origin of this pathway is the different monoaminergic nuclei in the 
upper brainstem and caudal hypothalamus: including serotoninergic dorsal (DR) 
and median raphe nuclei, the noradrenergic locus coeruleus (LC), dopaminergic 
ventral periaqueductal grey matter and histaminergic tuberomammillary neurons. 
The lateral hypothalamic peptidergic neurons (containing melanin-concentrating 
hormone (MCH) or orexin/hypocretin), and BF neurons (containing acetylcholine 
or GABA) serve to augment the input to the cerebral cortex (Saper et al., 2005). 
Posterior hypothalamus has been thought as a waking center due to its role in 
regulating of the sympathetic division of the autonomic nervous system. 
Collectively, the essential activating system had to be widened to include, in 
addition to the reticular formation, the posterior hypothalamus, hypothalamus-
subthalamus as well as the basal forebrain. These ventral extrathalamic relay 
which receive ascending input from the reticular formation to be projected in turn 
to the cerebral cortex , had shown to be able to keep activation of the cortical 
activation of the forebrain even in the absence of the signal’s input from the 
brainstem reticular formation and function thus independently as activating 
system.
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1.2.3 SLEEP GENERATING SYSTEM
Between 1940s and 1950s, many physiologists believed in an idea that 
sleep was a result of a decrease and fatigue in the activity of the reticular 
activating system. Nonetheless, sleep dimensioned by transections through 
different areas in the brain. Particularly, total insomnia resulted by transections of 
the brainstem behind the oral pontine tagmentum. This fact indicated that lower 
brainstem has important sleep generating system with capacity to antagonize the 
ascending reticular activating system in the upper brainstem. The clinicians also 
notice that in clinical cases, the disappearance or diminishment of the slow wave 
sleep accompanied lesions in the lower pons or medulla. This state was referred to 
as (alpha coma), which characterized by the predominance of alpha activity on 
EEG typically to wakefulness, while the subject showed lacking of the behavioral 
alertness and responsiveness.  
The finding that low frequency electrical activation of the medullary 
reticular formation, especially the dorsal medullary reticular formation and the 
solitary tract nucleus , in production of cortical slow wave activity in awake 
animals as well as the lesions of these structures which produce fast activity of the 
EEG in sleeping animals indicated the presence of neurons that could generate 
sleep. Solitary tract nucleus receive afferent fiber projections from 9th and 10th
cranial nerves, glossopharyngeal and vagus respectively, which transmit input 
from baroreceptors and chemoreceptors of the abdominal and thoracic viscera. 
Many of the ascending projections from solitary tract nucleus and dorsal 
medullary reticular formation reach and terminate in the parabrachial nuclei. 
These nuclei in turn project rostrally to the thalamus, preoptic areas, 
hypothalamus, amygdala and orbitofrontal cortex, areas commonly belonging to 
visceral limbic forebrain. The solitary tract nucleus project lightly forward to all 
these areas excluding the cortex. This data pointed out that the role of solitary 
tract nucleus may not only by the inhibition of the reticular activating system but 
also by an action on the structures of the forebrain which had implicated in the 
generation of sleep. Studies of Bremer with cerveau isole had shown that 
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forebrain could locate a crucial synchrogenic structures because cortical slow 
wave activity still appears in absence of the brainstem influence. Applying low 
frequency electrical stimulations in acute experiments studies of midline thalamus 
induced a slow cortical activity. Moreover, in chronic studies of thalamic 
stimulation, this initiated a natural sleep defined by both behavioral and EEG 
criteria. Such evidences led to consider thalamus as (head ganglion of sleep) 
(Jones, 2005). This conclusion was also supported from clinical case of (fatal 
familial insomnia), in which a selective degeneration of thalamic nuclei is 
associated with it. However, lesion studies showed that although thalamus may be 
necessary for the production of cortical spindles, it is not necessary for the 
creation of behavioral and cortical slow waves sleep as clarified by its complete 
removal (Villablanca et al., 1972). Since 1900s, anterior hypothalamus proposed 
as a center of sleep due to several cases of (encephalitis lethargica) in which the 
lesions were concentrated in this area and the patients were suffering of insomnia. 
This made Von Economo to posit that this area is in opposition to and 
normally in balance with waking center in posterior hypothalamus. Lesions 
studies in animals had confirmed the existence of sleep facilitatory regions in 
preoptic area and anterior hypothalamus. The ventrolateral preoptic area VLPO is 
a small neuronal core (radius 300 μm) located in the ventral POA, it was found to 
send outputs to all major brainstem and hypothalamic cell groups participating in 
the arousal (Sherin et al., 1996). The VLPO neurones contain the inhibitory 
neurotransmitters, galanin and GABA and they are primarily active during sleep 
(Gaus et al., 2002). These VLPO neurons form dense cluster and a more diffuse 
extended part of the nucleus. The main output to the LC and DR are provided by 
VLPO extended neurones, which are thought to be important in gating REM sleep 
(Lu et al., 2002). On contrary, the VLPO cluster more heavily innervates the 
histaminergic neurons, which are important to transitions between arousal and 
NREMS (John et al., 2004). On the other hand, each of the major monoaminergic 
systems sends afferent inhibitory input to the VLPO. However, VLPO does not 
have histaminergic receptors, but tuberomammillary neurons contain GABA also, 
which inhibit VLPO (Saper et al., 2005). 
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POA has beside VLPO, median preoptic nucleus (MnPN) which has sleep 
active neurones with a majority of MnPN neurons activated during sleep contain 
GABA as proved by the finding that a majority of its neurones expressing c-Fos-
immunoreactivity (IR) during sleep are GABAergic. Similar to VLPO, anatomical 
tracer studies reveal projections from MnPN to multiple arousal-regulatory 
systems in the posterior and lateral hypothalamus and the rostral brainstem to 
promote sleep onset and sleep maintenance by inhibitory modulation of these 
systems (Szymusiak et al., 2007). Furthermore, the electrical stimulation of the 
basal forebrain and preoptic areas resulted in appearance of drowsiness followed 
by behavioral and EEG patterns of natural sleep. 
Thus, the three areas i.e. preoptic area , hypothalamus, basal forebrain, 
together with lower brainstem were shown to be clearly important for the sleep 
generation. Subsequent evidences had shown that although the importance of 
these structure, but they were not sufficient for slow wave sleep and thus cerebral 
cortex and basal ganglia could contribute to onset of sleep also.
1.2.4 Non-REM SLEEP
Generally, in mammals the onset of sleep is associated with slowing of 
EEG activity, a rising of the EEG amplitude and decrease of muscle activity 
which followed in most species with appearance of the spindles (7 to 14 Hz). A 
shorthand definition of NREMS is “a relatively in active yet actively regulating 
brain in a movable body” (Carskadon and Dement, 2009). The alternation 
between NREM and REMS occurs in human in cyclic fashion. Usually, REMS
became longer across the night. Stages 3 and 4 occupy less time as the sleep 
cycles progress i.e. occupy less time in the second cycle and may disappear in the 
later cycles and stage 2 expands to occupy the whole NREMS. Approximately, 
the mean duration of the first NREMS-REMS cycle lies between 70 to 100 
minutes, whereas the second and later cycles is approximately 90 to 120 minutes. 
So, the average NREMS-REMS cycle across the night in normal subjects is 90 to 
110 minutes. Slow waves and spindling are the prominent hallmarks of the 
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mammalian NREMS or quiet sleep. Slow wave activity (SWA; 0.5 to 4 Hz) 
differs in its peak frequency between different species as it is concentrated at 
lower frequency in some species as human and rat. NREMS could be further 
subdivided into light and deep sleep depending on the amount of delta wave 
activity.
The classical stages of NREMS in humans are four however the new 
classification has made them three stages by merging the third and fourth stages in 
one stage. These four stages defined along one measurement, EEG. By passing 
from the first till the fourth stage, sleep being deeper and awakening is more 
difficult. Thus, one can consider that these four stages roughly parallel a depth of 
sleep continuum, with lowest thresholds of awake in stage one and highest in the 
fourth. Onset of sleep is accompanied with reduce of body temperature (Tb) and 
the Tb is actively regulated at lower level in sleep than during wakefulness. This 
idea came after the observations that in napping children, the decline in rectal 
temperatures coincided with elevated skin temperature as well as increasing of the 
evaporative water loss. It is commonly observed that in animal studies, the brain 
temperature (Tbr) falls during NREMS in comparison to the wake state, but in 
REMS it is higher than NREMS (Parmeggiani, 1980). The change in Tbr can be 
influenced by the change in blood temperature which perfusing it, change in the 
metabolism of the cerebrum or changes of the cerebral blood flow. Shivering in 
NREMS in cool environment occurs in stage 1 and 2 but not during the rest 
NREMS stage or the whole REMS indicating the marked inhibition of 
thermoregulatory response during REMS and intact thermoregulatory 
mechanisms in NREMS. The cause of this is the state dependent changes of the 
functions of preoptic hypothalamic thermostat neurons.
NREMS is characterized by a down-regulation of cardiovascular activity 
of variable intensity depending on the species and the previous level in quiet wake 
state. Blood pressure declines in cat but not in rabbit whereas this decrement is 
not consistent in rat (Lacombe et al., 1988). In human, this decrease in arterial 
pressure was noticed but to a varying intensity between different individuals with 
increase in the sensitivity of the baroreceptors. On the other hand, heart rate 
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shows significant decrease in rat but this was not statistically significant in rabbit. 
On the whole, cardiovascular changes in NREMS are consistent with the 
respiratory and thermoregulatory changes in a condition of postural and motor 
quiescence.   
1.2.5 REM SLEEP
REMS was discovered by Aserinsky and Kleitman in 1953. This state of 
sleep was first identified by most obvious behavior: rapid eye movement during 
sleep. Most adult mammals’ neocortex shows low voltage EEG during this phase 
while the hippocampus has regular high-voltage theta (4 to 8 Hz) waves 
throughout REMS. They noticed that EEG pattern during REMS closely 
resembled that of alert waking and they found that the subjects awakened from 
this state reported vivid dreams. Jouvet reported this observation and found in 
addition a loss of muscle tone (atonia) in REMS and called REMS as paradoxical 
sleep (Siegel, 2009). In addition to the above mentioned patterns of REMS, other 
classic criteria were also noticed during this type of sleep; erection tends to occur 
in men and clitoral engorgement in women. The pupil constriction (miosis), 
reflecting a parasympathetic dominance in the iris control. All these changes 
which are distinguished throughout REMS have been termed its tonic features. 
The brainstem is believed to be the key brain structure for generation of
REMS, in particular the pons and the neighboring portions of the midbrain. These 
areas in addition to hypothalamus contain neuronal cells that are maximally active 
during REMS and hence it called REMS-on cells and cells that are minimally 
active during REMS which called REMS-off cells. Subgroups of REMS-on cells 
use the transmitters; gamma-aminobutyric acid (GABA), acetylcholin, glutamate, 
or glycine. On the other hand, subgroups of REM-off cells use the transmitters; 
adrenaline, noradrenaline, seretonine, and histamine. The interaction between 
these two types of cells controls the key phenomena of REMS. The entire 
destruction of the areas of pons and midbrain can prevent the occurrence of
REMS while the partial damage to portions of brainstem can lead to abnormalities 
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of certain aspects of REMS especially the loss of muscle tone. Lesions in medulla 
and pons cause REMS to occur in the animal without atonia. During this 
abnormality, the animal exhibits during REMS locomotor activities and appear to 
attack imaginary objects. This syndrome shares with some commonalities in
REMS behavior disorders seen in human. In contrary, the activation of REMS
controlling areas creates muscle loss in antigravity and respiratory muscles. 
Collectively, the dorsal part of pontis oralis (PnO) and caudalis (PnC) 
nuclei contain the neurons responsible for REMS onset i.e. REMS-on neurones 
(Webster and Jones 1988). Another achievement in the regulatory mechanisms of
REMS was the ﬁnding that raphe nuclei serotonergic neurons and noradrenergic 
neurons from LC cease ﬁring speciﬁcally during REMS, i.e, show a REMS-off 
ﬁring activity, reciprocal to that of REMS-on neurons (Aghajanian and 
Vandermaelen, 1982). Recently, it was found that tuberomamillary nucleus-
histaminergic neurons and hypocretinergic neurons from the lateral hypothalamus 
depict a REMS-off ﬁring activity (Mileykovskiy et al., 2005; Takahashi et al., 
2006). Gating REMS occurrence by mutual interactions between REMS-on and 
REM-off neurons namely, reciprocal inhibitory interactions between cholinergic 
REMS-on and monoaminergic REMS-off neurons for REMS onset and 
maintenance is the well-accepted hypothesis.
A very small area of the dorsolateral pontine tegmentum which is called 
sublaterodorsal nucleus (SLD) has the ability to induce a long-lasting REMS-like 
hypersomnia after injection of two GABAA receptor antagonists: bicuculline or 
gabazine, (Boissard et al., 2002). Furthermorem, glycinergic neurons from the 
ventral and alpha gigantocellular (GiV) and raphe magnus nuclei were found to 
receive direct projection from SLD to generate atonia during REMS by direct 
projections to cranial and spinal motoneurons. GABAergic neurons within the 
ventrolateral part of the periaqueductal gray (vlPAG) and the dorsal deep 
mesencephalic reticular nuclei (dDpMe) gate REMS by inhibiting tonically 
REMS-on neurons from the SLD during SWS and waking (Fort et al., 2009). 
Melanin-concentrating hormone (MCH) has a role in REMS due to the finding 
that MCH neurons activation is selective for REMS (Hanriot et al., 2007). Luppi 
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et al. (2006) proposed that REMS increases induced by MCH might be as the 
result of the inhibitory direct effect of the GABAergic dDpMe and vlPAG 
neurons gating REMS onset while inputs to these areas from the HCRT neurons 
would be excitatory to prevent REMS. A relevant role for neurons localized in the 
lateral hyopthalamus in the regulation of REMS occurrence came from a recent 
paper (Clement et al., 2012) in which it has been shown that the inhibition of the 
lateral hypothalamus by the local microinjection of muscimol suppressed REMS 
occurrence in the rat. The results have been interpreted as being the effect of the 
tonic suppression of the activity of the MCH neurons which are intermingled and 
in close functional relationship with the HCRT ones. Moreover, a role in the 
promotion of REMS occurrence has been attributed to the peptide Nesfatin-1 
which is co-expressed in MCH neurons in the tuberal and lateral zone of the 
hypothalamus and has been shown to be also involved as a satiety factor in 
appetite regulation (Jego et al., 2012)
From the point of view of physiological regulation, the two sleep states are 
very different (Parmeggiani, 2005), since while NREMS is characterized by a 
substantial stability of the autonomic parameters which are typically regulated in 
accordance with Walter Cannon’s homeostatic paradigm, REMS is characterized 
by a large autonomic instability, with sudden surges in arterial blood pressure and 
heart rate and profound irregularities in breathing. In particular, during REMS 
thermoregulation is depressed or suppressed in different species and the animal 
body temperature shift toward the environmental temperature as reptiles 
(Parmeggiani, 2003). This led to define REMS as a poikilostatic state, in contrast 
to NREMS (Parmeggiani, 2005).
The interest in deepening the relationship between sleep and 
thermoregulation comes from the fact that these two functions influence each 
other. The thermoregulatory regulation changes during sleep, also the structure of 
sleep changes during the thermoregulatory activity. This close interaction was 
probably driven by the fact that these two functions share some of the regulatory 
structures at the central level, in particular, the basal preoptic regions and ventral 
nuclei of the hypothalamus. As already said, the main thermoregulatory difference 
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which is observed during the wake-sleep cycle is the thermal homeostasis 
suspension during REMS, which has been observed in many species, including 
humans, and has been postulated that this impairment generally depends on 
insufficiency in the hypothalamic integration of autonomic function (Heller, 2005; 
Parmeggiani, 2005). During REMS, animals exposed to high or low ambient 
temperatures were missing the normal thermoregulatory responses such as 
shivering, the thermal polypnea and vasomotor responses. Experimental animal
had shown highest total sleep time at thermonutral ambient temperature and
decreases both in the cold to hot and that REMS is the one most affected by the
variation of the ambient temperature. Amici et al., (1994); Cerri et al. (2005) 
confirmed this in the rat, where they observed that the amount of REMS is 
reduced almost to zero in extreme environmental conditions. However, Luppi and 
colleagues (2010) reported that  osmoregulation, is not impaired during REMS, 
so, we can now suppose that the link between REMS and suspended homeostasis 
is prevalently (or exclusively) linked to suspended thermoregulation and therefore
REMS function could be precisely related to the regulation of body temperature 
and metabolism.
Furthermore, blood pressure in human, rat and rabbit show an increase 
from NREMS to REMS but this rise was not always accompanied with primary 
cardiovascular changes namely; heart rate and vascular conductance. In rabbit, 
decrement during REMS was noticed in renal and vascular conductance. The 
weak correlation between regional and systemic variables proves that the central 
integration of cardiovascular functions is altered during REMS. The variability in 
heart rate and blood pressure is a prominent and an important feature of REMS in 
rabbit, rat, cat and human being and it is loosely associated with bursts of rabid 
eye movements, myoclonic twitches and more often probably with breathing 
irregularities. The main causes of such instability of cardiovascular regulation in 
REMS are due to the interaction between the central variabilities of visceral 
control and the central effects of activated reflexes. In rat, during REMS, the 
arterial blood pressure (BP) increases (hypertension) while in sinoaortic 
denervated counterparts, hypotension occurs as in cat. 
37
There is a mode of description of the succession of episodes of different
REMS which is based on the possibility to describe the succession of episodes of
REMS regardless of the phase of the sleep cycle interposed between two
successive episodes of REMS, but simply taking into account the duration of the 
time interval which separates the two mutually adjacent episodes. The study of the 
frequency distribution of the duration of the intervals between two consecutive
REMS episodes, namely the intervals of time after the end of an episode of REMS
and the beginning of the next, showed a bimodal characteristic appearance that
varies in a species-specific. In rats, 3 minutes has been shown to be the time 
interval that identifies the limit of separation between short and long episodes of
REMS (Amici et al., 1994). As mentioned above, one can distinguish individual
episodes of REMS, which are separated by intervals of duration greater than 3 
minutes (single REMS episodes), and sequential episodes, which are separated by
intervals of less than 3 minutes (sequential REMS episodes). More episodes of
REMS sequential occur in groups known as REMS clusters, in which the first and
the last episode are separated from the previous and next respectively by long
REMS intervals. Amici and colleagues (1994) had reported that during the normal
circadian rhythm of light-dark in rat, about half of the REMS is executed in the 
form of sequential episodes. Moreover, it has been shown that REMS occurrence 
is mainly regulated through changes in sequential REMS episodes either under 
thermal challenges (Amici et al., 1994, 1998; Cerri et al., 2005) or in response to 
changes in environmental light ( Zamboni et al., 2001), while the amount of single 
REMS episodes is kept almost constant, if possible. The partition between single 
and sequential REMS episodes is therefore considered to be a good index 
describing the interaction between REMS pressure (increasing sequential REMS 
episode) and the activity of the autonomic nervous system dedicated to the 
conservation of bodily homeostasis (depressing sequential REMS episodes)
(Amici et al.,1994; Zamboni et al., 2004).
In this thesis, the amounts of REMS under the form of sequential REMS 
episodes or single REMS episodes will be addressed as Sequential REMS or 
Single REMS, respectively. 
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1.2.6. SLEEP HOMEOSTASIS 
Both the amount of sleep and the dynamics of its recovery after 
deprivation suggest a kind of homeostatic regulation for sleep occurrence. In the 
80s, Borbély was the first to address the issue of sleep regulation in term of 
intensity and the duration (Borbély, 1980). According to his model, the propensity 
to sleep state is the result of the interaction of two processes, called process C and 
process S. The process C, or circadian, describes the control of the timing of 
episodes of sleep and sleep propensity during the day, and derives from the supra-
chiasmatic nucleus of the hypothalamus (SCN). The process S, or homeostatic, 
describes how the sleep propensity increases proportionally to the accumulation of 
the time spent in wakefulness and decreases, instead, after periods of sleep, 
especially during NREMS.
Therefore, it can be said that sleep is a behavioral state during which, in 
the NREMS phase, physiological variables are homeostatically regulated, but it is 
also true that the same state of sleep is subjected to a homeostatic regulation. An 
indicator of the intensity of NREMS, and, therefore, used to describe the 
homeostatic process below, consists of the electroencephalography slow-wave 
activity (SWA), with a meaning equivalent to that of Delta waves. The reason 
why SWA serves as an index of the intensity of NREMS is due to the fact that it is 
particularly intense at the beginning of a phase of sleep, precisely parallel to the 
period in which the threshold of awakening organism is the most high and, 
therefore, the sleep becomes deeper. After this first phase, the need for sleep is 
reduced and, simultaneously, SWA becomes much less intense also. Furthermore, 
in many studies it has been observed that periods of deprivation are followed by 
intense SWA in the recovery phase of sleep (Borbély and Achermann, 2005). The 
SWA is not, therefore, only an epiphenomenon of NREMS, but it reflects 
important regulatory mechanisms, the meaning of which is still matter of debate. 
To date, the most accepted theory to explain the homeostasis of NREMS
SWA is synaptic homeostasis (Tononi and Cirelli, 2003). This theory relates the 
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synaptic potentiation during wakefulness, with the SWA during sleep. 
Specifically, the different activities during wakefulness (such as, reactions to 
sensory stimuli, motor activity, mental associations, thoughts, acquire new 
experiences) lead to an increase in the number and strength of synaptic 
connections between neurons (synaptic potentiation); this phenomenon is directly 
correlated with the increase of the SWA during the next sleep phase, the function 
of which would be an elimination of synaptic connections considered superfluous. 
From this point of view the progressive decline of the SWA during rest reflect the 
corresponding re-modulation of synaptic weights in order to optimize the 
functionality of neuronal connections. The function of the slow-wave activity 
during NREMS, according to this theory, would therefore be to avoid overload of 
synaptic connections on nerve cells, thinning the density of connections and at the 
same time improving their efficiency.
In contrast to NREMS, REMS does not present dynamics of recovery 
based on the intensity, but rather on the duration of the phenomenon (Parmeggiani 
et al., 1980b; Cerri et al., 2005). In fact, it is not yet clear whether the REMS
recovery is also based on an increase in the intensity of theta waves, typical of this 
stage of sleep (Cerri et al., 2005). A procedure that has allowed a detailed study of 
the dynamics of recovery of REMS consisted of exposure to low temperatures 
which is a powerful inhibitory stimulus against the appearance of REMS. After 
exposure to cold, in the rat the recovery process of REMS appears to depend only 
on the amount of REMS lost during the previous deprivation, following a 
dynamic seems that regardless of the temperature of exposure (Amici et al. 2008). 
After 24-h deprivations of REMS of different intensities, this process leads to a 
100% recovery of the REMS loss in few days (Amici et al. 2008). From studies of
deprivation and recovery, it is clear that REMS behavior is a finely regulated on 
the homeostatic base and how the chronic deprivation of this phase of sleep
represents a severe stress for the organism so as to lead to an organic deterioration
such as to induction of death (Rechtschaffen et al, 2002). As mentioned earlier, 
the chronic deprivation of REMS is accompanied by a dysmetabolic syndrome
characterized by the reduction of the production of leptin followed by appearance 
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of hyperphagia, contrary to what the body weight is reduced gradually, while the 
metabolic activity of fat brown increases (Koban and Swinson, 2005). This 
suggests that REMS is involved in the maintenance of the metabolic activity of 
the organism and that behavior is essential for the biological economy of the 
individual and his own life. In support of the hypothesis of a link between REMS
and metabolic function, it has been shown that the intensity of the REMS rebound 
following REMS deprivation, and therefore the REMS need, apparently decreases 
in proportion with the increase in the body mass (and therefore with the decrease
of the basal metabolic rate per Kg) of the different species, being more urgent in 
rats than in cats, and reaching a lower level in humans (Amici et al. 2008).
1.3 CARDIOVASCULAR PHYSIOLOGY AND SLEEP
Cardiovascular autonomic system is a highly network integrates to keep 
visceral functions under control, which in a short timescale (within second to 
hours), can adjust the circulation in keeping with, environment, emotions and 
behavior. Ensuring adequate cardiac output to the vital organs through continuous 
and rapid adjustment of HR, arterial BP, and redistribution of blood flow, is 
counted as the primary and main role of this system. This neural circulatory 
regulation seems to be in the longer term unfolds the coupling with the circadian 
rhythms, W-S cycle, and some ultradian rhythms ; including REMS and NREMS
stages, in addition to hormones implicated in the long term with BP control.
The perturbations of the regulation of cardiovascular system during the 
nocturnal sleep is crucial for the public health and this is underscored by the 
estimated annual sleep related cardiac events which accounts for 20% of 
myocardial infarctions or (250,000) and 15% of sudden cardiac deaths or (48,750) 
in United states (Eckberg and Sleight, 1992). Typically, during night’s sleep, a 
wide spectrum of autonomic patterns uncovers which provides cardiovascular 
system with respite or stress. These effects are due to the fine toned or harmonic 
changes in physiology of Central Nervous System (CNS) as the periodic 
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reexcitation of the brain during transition from relative tranquility in NREMS to
REMS. 
1.3.1 SLEEP STATE-CONTROL OF CARDIOVASCULAR FUNCTION
Blood pressure undergoes wide physiological changes between Wake-
Sleep states (Silvani, 2008). During NREMS, arterial pressure substantially 
decreases with respect to Wake in humans (Silvani et al., 2008) and rodents 
(Silvani et al., 2009) because of decreases in cardiac output and vascular 
resistance (Silvani, 2008). During REMS, an apparent re-patterning of 
sympathetic activity to cardiovascular effectors causes changes in arterial 
pressure, the direction and magnitude of which are highly sensitive to genetic and 
pathological factors (Silvani, 2008).
The initial stage of sleep cycle, namely, NREMS is characterized as a 
period of relative autonomic stability with dominance of vagal nerve and 
hightened baroreceptors gain. Normal respiratory sinus arrhythmia is a term used 
to describe a near sinusoidal modulation of heart rate (HR) variation occurs as a 
result of a coupling with respiratory activity and cardiorespiratory centers in the 
brain during NREMS stage. Inspiration induces a brief accelerations of HR in 
order to accommodate increased venous return, resulting in increased cardiac 
output , while progressive deceleration ensues during expiration. This variability 
in HR, particularly in NREMS, is considered normal and it is generally indication 
of cardiac health whereas, the absence of this phenomenon is related to aging and 
cardiac pathology. Also, during breathing, a reflexive cardiovascular alterations 
manifested as cyclical differences in HR which also have an inverse relationship 
as a transient increase in arterial blood pressure results in slowing, interruption or 
decrement of the breathing efforts. During sleep, this effect is enhanced when 
even a small reduction in BP induces increase in respiratory rate (Lombardi and
Parati, 2000). These pauses or increasing heart rates needed as compensatory 
mechanisms and to normalize the arterial BP. The absence of these normal pauses 
and dimensioned breathing variation in addition to reductions in respiration 
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induced HR difference, are a characteristic finding in infants who later suffer from 
sudden infant death syndrome (SIDS). Furthermore, reduced HR variability is 
typically associated with another infant syndrome which called congenital central 
hypoventilation syndrome, in which the respiratory drive is lost during sleep. 
Obstructive sleep apnea (OSA) is accompanied with extreme HR variation. 
Thus, loss of normal vagal nerve function is the common factor of cardiac risk 
associated with suppressed HR variability. Bernardi et al. (1990) reported that 
sympathetic nerve activity tends to be relatively stable during NREMS and from 
wakefulness to stage four of NREMS, the cardiac output reduced by more than 
50%. This stability of autonomic functions of NREMS, with hypotension, 
bradycardia, and reduction in cardiac output and systemic vascular resistance, 
support the body with relatively healthy neurohumoral background during which 
the heart has a chance for metabolic restoration. These two phenomena; 
bradycardia and hypotension are believed to be caused mainly by increase 
parasympathetic nerve activity and sympathetic vasomotor tone reduction, 
respectively (Pagani et al., 1986). Bursts of vagal nerve activity during the 
transitions from NREMS to REMS are accompanied with the occurrence of 
pauses in heart rhythm and frank asystole. Particular attention should be given to 
the cardiovascular regulation during REMS as the instability and perturbations 
occur due to loss of integration between forebrain structures and brainstem which 
makes these pronounced changes to be attributable to distinct mechanisms related 
to specific brain sites rather than demonstrating an autonomic change continuum.
REMS which started at 90 minutes intervals can disrupt cardiorespiratory 
homeostasis. The increased activity of brain during REMS causes the major 
surges in cardiac sympathetic nerve innervation to the coronary vessels. 
Baroreceptors gain was found to be suppressed during REMS phase also. 
Obvious fluctuations of HR, with marked episodes of both bradycardia and 
tachycardia were reported. As the individual inters the REMS, the efferent vagal 
tune to the heart is, in general, suppressed and subsequent high irregularity in 
respiratory rhythmicity initiates which can lead to reduction in the oxygen level 
that affects in particular those patients with pulmonary or cardiovascular diseases 
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(Mancia, 1993). Neurons responsible about activating principal diaphragmatic 
muscles are normally escape from this generalized suppression although the upper 
airway and the accessory muscles show inhibition of their activity. This inhibition 
is prominent in can be noticed in infants abdominal and thoracic muscles during 
REMS. Sleep apnea, a case which is known to exaggerate in obesity, might be 
accompanied with interruption of central respiratory activity or peripheral 
obstruction hundred times each night, with the possible terrible consequences for 
cardiorespiratory activity. The pontine and suprapontine structures have shown a 
capability to alter cardiorespiratory patterns during sleep and wake states. The 
important of pontine area as a key player in REMS activation is well known and 
demonstrates a preferential activation of limbic and paralimbic regions in 
forebrain compared with NREMS and wake (Nofzinger et al., 1997). 
Furthermore, the serotonergic neurons which exist in midline raphe of the pons 
have an important role in vascular control as in cases of heart failure, patients 
demonstrate loss of these neurons which it is likely as a results of hypoxia and 
impaired perfusion during impaired breathing while sleep in this condition (Woo 
et al., 2009). Other cerebral structures are frequently included among the 
forebrain structures which ruling the cardiorespiratory patterns in addition to 
affective behavior as orbital frontal cortex are hypothalamic structures as well as 
portions of the hippocampal formation. The central nucleus of the amygdala is a 
cornerstone in regulating cardiac and respiratory functions due to its extensive 
projections to other brain structures known to have a significant influence on 
cardiac action namely; barabrachial pons and the nucleus of the solitary tract, the 
dorsal motor nucleus and the periaqueductal gray region. These structures are 
recruited by inspiratory and expiratory loading that takes place during the 
impairment of breathing through sleep. The insular cortex deserves special 
interest over other areas responsible of the cardiovascular control during sleep and 
wakeful. The importance of this area is being the area both sympathetic and 
parasympathetic actions in both animal and human studies. However, there is an 
interaction between right and left sides of insular cortices, the right side is 
responsible about the control of sympathetic outflow while, the left side controls 
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the parasympathetic one (Verrier et al., 2009). Under conditions with sleep 
disordered respiration and high sympathetic tone i.e. heart failure and OSA, 
marked deficits were noticed in the insula. Moreover, Cerebellum has a particular 
role in controlling the cardiovascular and respiratory functions, although it is not 
classically considered as a component of either respiratory or cardiac control. A 
part of this role in regulation BP is via cerebellar-vestibular mechanisms. 
Vestibular mechanism has a role in adjusting BP during a fast change in the 
posture which is normally seen as syncope in hypotensive patients when rise from 
horizontal position. Ineffective compensatory responses to hypotension with 
subsequent death were accompanied with lesions in the cerebellar fastigial 
nucleus. OSA and heart failure cases were found to be accompanied with 
cerebellar damage with prominent loss of gray matter in its cortex and deep 
nuclei.     
1.3.2 SYMPATHETIC VS PARASYMPATHETIC CONTROL 
Circulation is under the neural control which appears via vagal nerves 
effect on the heart and sympathetic nerves efferents operate to heart, blood 
vessels, kidneys as well as adrenal medulla. Cardiovascular stimulation is 
occurred primarily via vagus nerve by activation of the muscarinic receptors 
resulting in bradycardia. In contrast, the sympathetic stimulation of the heart is 
induced by activation of β1 adrenoceptors at the cardiac pacemaker i.e. sinoatrial 
node (SA node) and the cardiac muscles (myocardium) which increased 
contractility and results in tachycardia. Moreover, the sympathetic activation on 
the vascular beds entrains several effects demonstrated as vasoconstrictions by 
activation α1 adrenoceptors in the skin and splanchnic districts but in contrary, 
vasodilatation by stimulation β2 receptors in the heart and skeletal muscles. Both 
efferent’s activity of sympathetic and parasympathetic to the heart might also alter 
electrophysiological properties of the heart which can in turn create several types 
of arrhythmias, especially in the existence of proarrhythmic substrates.
45
1.4 THE RECIPROCAL INTERACTION BETWEEN SLEEP 
DISTURBANCES AND OVERWEIGHT
In fact, the association between sleep disturbance and excessive body 
weight had been known since the sixties of the last century, when it was described
the occurrence of episodes of sleep apnea in severely obese patients (Gastaut et 
al., 1965). The obstructive sleep apnea (OSA) is classified as part of the intrinsic
hypnic disorders characterized by disturbances of breathing (sleep-related 
breathing disorders; Vgontzas et al., 1998). The OSA can be interpreted as an 
early symptom of the so-called metabolic syndrome (metabolic syndrome, MS), 
as it is often characterized by the appearance of insulin resistance independent
from overweight which can continue to the emergence of obesity and the 
framework of the full-blown MS (Vgontzas et al., 2005).
The MS is manifested by the appearance of a set of symptoms that 
contribute to increase the probability of occurrence of a type 2 diabetes and 
cardiovascular disease namely; obesity, arterial hypertension, high level of 
triglycerides, low HDL cholesterol level and hyperglycemia (Ryden et al., 2007). 
The definition of MS is continuously subjected to review and refresher courses, 
either for new addition to the collection of symptoms parameters, or for the 
elaboration of clinical data by different organizations or professional associations. 
The current accepted definitions are five, and they differ mainly for the 
threshold level established for pathological metabolic parameters (Graham et al. 
2007). The association between obesity, OSA and hypnic disorders remained 
limited for a long period in a field of research and the main goal was for refining 
the definition of the various comorbidities. Webb and Agnew (1975) were the first 
in separation the hypnic disorders by the possibility of a reduction of sleep time in 
relation to a socially determined lifestyle. This observation was followed 
sporadically by others until the first systematic relationship to the insufficiency of 
sleep in a large population sample (Broma et al., 1996). This study, conducted in a 
Swedish community, reported that regardless of gender and age, about 6% were 
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suffering of sleep curtailment attributed to social reasons rather than to sleep 
disorders as insomnia. In 1999, a study by Spiegel et al. was decisive step in 
determining the relationship between this reduction in sleep and metabolic status 
of individuals. These authors had shown how forced sleep deprivation in young 
during six consecutive nights related to reduction of glucose tolerance, a reduction 
in blood levels of Thyroid-stimulating hormone (TSH) , an increase of cortisol in 
the afternoon and evening and a shift of sympatho-vagal tone to the sympathetic 
tone. The key idea in this study is the appearance of one of the cardinal symptoms 
of the evolution of the MS, such as impaired glucose tolerance following a partial 
sleep deprivation for a short period. Although the relation between chronic 
reduction of sleep and the development of obesity is not clearly shown, one could 
infer that the simultaneous appearance of early signs of metabolic disorder in a 
sleep curtailment subjects for a short period was able to lead to a causal 
relationship simply turning partial deprivation in a prolonged state.
This topic could not be addressed experimentally in human due to ethical 
reasons as in order to study this point, we need to modify the life style for long 
period. In order to overcome this problem we can progress in two ways: 1) the 
animal model, although this will give us a partial solution as it is not possible to 
change the behavior of the animal chronically without a very stressful constraint, 
and for that the animal model can be excellent in studies related to partial sleep 
deprivation; 2) human being, in which we can conduct retrospective 
epidemiological studies on large and well defined human populations.
In 2002, and particularly on North American adolescents, was the first 
human defined cohort on whom it was studied the relationship between sleep 
reduction and the pathological weight gain (Gupta et al., 2002). It was concluded 
that poor sleep quality proved to be significantly related to obesity. This finding 
was also confirmed by another study performed by Hasler et al. (2004) on a 
population of young adults lasted for 13 years. These conclusions were certainly 
in line with the alarm of obesity (WHO, 2003), but the epidemiological approach 
more accurately determined sleep curtailment and the appearance of glucose 
metabolism disorder were confirmed by the critical review of Spiegel et al. (2009) 
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who put into consideration the relationship between the prolonged sleep reduction 
and the appearance of insulin resistance, the early symptom which possibly 
develops toward type 2 diabetes. Also, the authors highlighted the role of sleep in 
the regulation of food intake and appetite and overthrew the relationship between 
obesity and OSA assuming that sleep fragmentation, primitively induced the 
OSA, to explain the association with obesity in patients suffering from this 
respiratory disorder. In this work relationship existed between control of food 
appetite and control of sleep. Such hypothesis of the relationship was first made in 
a study for a couple of years in adult subjects in both sexes, determining the 
concentration of two satiety hormones which regulate the food appetite and their 
roles in sleep curtailment and how this relation was highly correlated to the 
increase of BMI (Taheri et al., 2004); another relevant and new data of this work 
was the finding of U-shaped pattern of the relationship between BMI and sleep 
duration. In persons sleeping less than 8 h, increased BMI was proportional to 
decreased sleep. Similarly, in their study to explore the relationship between sleep 
duration and diabetes incidence over an 8- to 10-year follow-up period, 
Gangwisch et al. (2007) found that  subjects with sleep durations of 5 or fewer 
hours (odds ratio = 1.47, 95% conﬁdence interval 1.03-2.09) were signiﬁcantly 
more likely to have incident diabetes over the follow-up period after controlling 
for covariates. They reported also that subjects who slept 5 or fewer hours were 
almost twice as likely as those who slept 7 hours to have incident diabetes over 
the follow-up period. Another study by Gangwisch and colleagues (2006) 
mentioned that subjects between the ages of 32 and 59 years who reported 
averaging 5 hours of sleep per night were at an increased risk for developing 
hypertension over the follow-up period (8- to 10-year).The impact of recurrent 
sleep curtailment had reported to lead to weight gain and obesity by 
compromising insulin sensitivity and by increasing appetite by decreasing leptin 
levels and increasing ghrelin levels. Other study performed on the  data of 4222 
Korean participants revealed that in subjects under 60 years old the prevalence of 
abdominal obesity and hypertension were highest in subjects who slept <5h per 
night whilst those who slept 7 hours have the lowest prevalence for MS (P=0.006) 
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(Choi et al., 2008). On the other hand , the finding that the relatively few obese 
adults/children are short sleepers, and few short sleeping adults/children are obese 
or suffer obesity related disorders makes some researcher as Horne (2008) 
mention that many years of changing in sleeping manner are needed to show any 
weight or BMI differences between short, normal, and long sleepers. Furthermore, 
he reported that the a BMI difference of 2.5 units (about 7 kg) between otherwise 
comparable short (5 h) and normal (7-8 h) sleepers, developed slowly during 10 
years of such sleep; that is, with hundreds or even thousands of  hours difference 
accumulated in the daily sleep between the two groups over this 10 y period. 
According to the author this would show that the effects of poor sleep on the 
development of obesity have probably been overestimated.
1.5 STATE OF THE ART 
1.5.1 THE OBESITY EPIDEMIC IS A THREAT TO HEALTH CARE  
The prevalence of obesity has risen dramatically worldwide (WHO, 2006). 
In Europe, an estimated 150 million adults are overweight or obese, thus, obesity 
represents one of the most serious public health challenges (WHO, 2007). Obesity 
also predisposes to coronary heart disease, heart failure, and sudden death (Poirier 
et al., 2006). Abdominal obesity tends to cluster with glucose intolerance, insulin 
resistance, dyslipidemia, and hypertension, which are documented risk factors for 
cardiovascular disease, leading to a constellation of metabolic abnormalities 
known as the metabolic syndrome (Eckel et al., 2005). In particular, obesity is 
associated with hypertensive derangements of arterial BP, which are most 
prominent during the rest period of the daily rest-activity cycle. This phenomenon 
and its underlying mechanisms are of great clinical interest because a blunted 
nocturnal decline in arterial BP (non-dipping) and high nocturnal arterial BP
values are recognized as powerful predictors of mortality in patients referred for 
ambulatory arterial BP monitoring and the general population.
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1.5.2 ANIMAL MODELS ALLOW MECHANISTIC INSIGHT ON THE 
PATHOPHYSIOLOGY OF OBESITY
In general, obesity and other metabolic syndrome traits in humans ensue 
from interactions between polygenic susceptibility and an obesogenic 
environment (Lusis et al., 2008). The understanding of the mechanisms of these 
interactions can be hastened by studying animal models of diet induced obesity 
(DIO), which present critical features of obesity in humans. Interestingly, it has 
been shown that when Sprague-Dawley rats are fed an energy-dense diet, rich in 
saturated fat, only about 50% of them develop obesity (obesity-prone, OP), while 
the others appear to be resistant to DIO (Levin et al., 1983, 1997). In OP rats, DIO 
is associated with derangements of glucose metabolism and reduced glucose 
tolerance (Levin et al., 1997), hypercholesterolemia (Dobrian et al., 2000), 
hypertriglyceridemia (Dobrian et al., 2000), hyperleptinemia (Levin et al., 2003), 
and hypoghrelinemia (Levin et al., 2003). 
1.5.3 HYPERTENSION IN DIET INDUCED OBESITY
In obese humans, arterial BP is higher than in lean controls and decreases 
less than in lean controls on passing from the diurnal activity period to the 
nocturnal rest period (Kotsis et al., 2005). The risk of developing frank 
hypertension is 6 time larger in obese subjects than in lean ones (Poirier et al., 
2006). During the period with light on (i.e., the rest period in nocturnal mice), 
hypertension is also enhanced in mouse models of morbid obesity because of 
genetically impaired leptin signaling (Swoap , 2001; Silvani et al., 2009) as well 
as in C57BL/6J mice with DIO (Williams et al., 2003). The mechanisms 
underlying hypertension during the rest period in obesity are of great clinical 
interest because a blunted nocturnal decline in arterial BP and high nocturnal BP 
values are powerful predictors of mortality (Ohkubo et al., 2002; Dolan et al., 
2005). High values of arterial BP during sleep may result from sleep 
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fragmentation (Carrington and Trinder, 2008, Matthews et al., 2008) and sleep 
apneas (Parati et al., 2007; Hla et al., 2008). The circadian distribution and quality 
of wake-sleep episodes are major determinants of the circadian arterial BP rhythm 
because they contribute to differences in arterial BP between activity and rest 
periods (Kerkhof et al., 1998; Smolensky et al., 2007). 
At present, however, it is still unclear whether OP rats are susceptible to or 
protected from obesity-associated hypertension, since while the development of 
hypertension have been shown after 8-10 weeks of administration of a 
hypercaloric (HC) diet (Dobrian et al., 2000), this observation has not been 
subsequently confirmed (Carroll et al., 2006). However, while in the first study 
arterial BP determination was made by tail-cuff method, which is considered quite 
obsolete and not fully reliable, in the second study the determination was made by 
the state of the art method, i.e. by means of a telemetric transmitter implanted in 
the abdominal aorta. It is worth noting, that, at present, no W-S state dependent 
determinations of arterial blood pressure have been conducted in obese rats. 
1.5.4 OBESITY ENTAILS ALTERATIONS IN WAKE-SLEEP STRUCTURE 
AT ULTRADIAN AND CIRCADIAN TIME SCALES
In human subjects and animal models, the development of obesity is 
associated with alterations in wake-sleep structure. The consequences of these 
alterations on cardiovascular function remain poorly understood. In obese 
humans, excessive daytime sleepiness is associated with poor quality of sleep at 
night (Vgontzas et al., 1994,1998) particularly because of sleep apneas (Vgontzas 
et al., 1994). However, sleep apneas are not the only causative factor of excessive 
daytime sleepiness in obese subjects (Vgontzas et al., 1998). The tight link 
between sleep and obesity has also been stressed by recent data showing that sleep 
deprivation and chronic sleep loss are related to weight gain and to the 
development of insuline resistance and type-2 diabetes (Spiegel et al., 2008). 
The relationship between obesity and sleep has been studied in several 
animal models of obesity. These models develop obesity following the 
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administration of a high-calorie diet or through genetic manipulations aimed at 
manipulating the leptinergic system. In the second case, the animals have been
deprived of the ability to produce leptin (ob/ob mice) or have become resistant to 
the action of the hormone itself through the induction of a mutation of the 
hypothalamic receptor for leptin (db/db mice) or after being rendered incapable of 
expressing the same receptor (fa/fa Zucker rat). The absence or ineffectiveness of 
leptin that is normally produced from energy deposits in adipose tissue and signals 
to the hypothalamus of the magnitude of those deposits prevents the appearance of 
inhibition of food intake and body metabolism activation that normally follows an 
increase in the size of energy store. All these studies showed the trend in obese 
animal to increase the amount of NREMS, while variable results have been seen 
on REMS and the daily distribution during L or D periods of the Wake-Sleep 
states. 
In particular, the ob/ob mice, shows an increase of NREM sleep and a 
significant attenuation of the amplitude of the normal LD distribution of NREMS 
and REMS compared to their controls (Laposky et al., 2008; Silvani et al. 2009), 
mostly due to an increase in the amount of NREMS during the daily activity 
period (Dark). Similar results were observed in db/db mice (Laposky, 2008), 
showing a concomitant reduction of the daily amount of REMS. In mice that are 
obese because of dysfunctional leptin signalling, a significant sleep fragmentation 
is observed as well (Laposky et al., 2006, 2008). Studies on Zucker fa/fa rats also 
showed an increase of NREMS, but no effects on REMS sleep and LD 
distribution of W-S states (Danguir et al., 1989; Megirian et al. 1998).
Studies on mice made obese by the administration for 4-8 weeks of a 
hypercaloric (HC) diet showed a consistent tendency to an increase in the amount 
of NREMS, and less consistently, of REMS, in the absence of any significant 
change of the LD distribution of the Wake-Sleep states (Jenkins et al., 2006; Guan 
et al, 2008). The only published study conducted on rats subjected to high-energy 
diet (Danguir et al., 1987) showed that after 10 days from the start of the 
administration, the animals, which were still not significantly overweight 
compared to controls, tended to increase the amount of NREMS and REMS, 
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without apparent changes of the LD distribution of the Wake-Sleep states. Finally, 
recent data from our laboratory (Laudadio, 2011), that still have to be published 
on the international literature, have shown that in OP rats fed a HC diet for 8 
weeks REMS occurrence is increased compared to lean animals, but the normal 
increase in REMS occurrence which is usually observed when the albino rat is 
kept in the absence of environmental light (continuous darkness) is dampened. 
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2. Aims
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The aim of this research is to study the structure of the W-S cycle and the 
possible state-dependent changes of brain temperature and cardiovascular function
in rats made obese by the chronic administration of a hypercaloric diet.  
This study goes to fill a gap in the scientific literature related to this topic, 
since, as previously pointed out, no studies of this kind have still been conducted 
in the rat, which is currently the most widely used animal model in experimental 
biology. At present, studies of this complexity have been carried out exclusively 
in a mouse model of obesity induced by a genetic modification leading to the lack 
of the hormone leptin, in which the syndrome develops due to functional lesions 
that are not usually present in human pathology. Thus, it would be very useful to 
have an animal model in which the development of obesity and of possible 
cardiovascular comorbidities are induced by the administration of a hypercaloric
diet, since it would be very similar from a patho-physiological point of view to 
what normally occurs in humans. 
This experiment has also been conducted with the aim of identifying 
whether and, if the answer is positive, what are the changes made by the 
prolonged administration of a hypercaloric diet to sleep regulation in response to a
previous sleep deprivation. Particular care has been placed in the analysis of the 
possible modifications of REMS, whose occurrence is strongly influenced by the 
degree of activation of thermoregulatory/metabolic processes and is under the 
control of central nervous structures at hypothalamic level that are known to be 
also involved in the regulation of body temperature/metabolism and food intake.
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3.Material and Methods
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3.1 ANIMALS
The experiments were conducted using outbred CD Sprague-Dawley male 
rats (Charles River) of an age of 5 weeks and a weight comprised between 100 
and 125 g at the time of purchase. The animals, after their arrival, spent a week in 
the animal house and have been adapted to normal laboratory conditions: ambient 
temperature (Ta) 25 ± 1 ° C, light-dark cycle (cycle LD) 12h: 12h (L 9:00-21.00), 
light intensity at the level of the cages 150 lux; food and water ad libitum. During 
the week of adaptation the animals were housed in pairs in transparent plastic 
cages (Techniplast) containing bedding depolverate that were changed every two 
days. All animals were weighed with an electronic scale twice a week, from the 
day of arrival in the laboratory until the end of the experimental procedure.
The animals were divided into two groups: control and treatment. Obesity 
was induced in the treatment group (n=24) by administering an obesogenic 
hypercaloric-hyperlipidic (HC) diet starting from the 5th week of age for 8 
consecutive weeks (D12492: 35% fat, 60% calories from fat, Mucedola). Control 
group (n=16) was fed a standard normocaloric (NC) diet (D12450B: 3% fat, 10% 
calories from fat, Mucedola).
Starting from the seventh week of their arrival and, subsequently, in 
agreement with the experimental plan (see EXPERIMENTAL PLAN) the animals 
were subjected to surgery. The experiments were performed in accordance with 
European Union Directive (86/609/EEC) and under the supervision of the 
Veterinary Service Center of the University of Bologna and the National Health 
Authority.
After 7 weeks of the diet regime, the weight of the animals were (NC: 441 
±16g; HC: 556±17g): data are mean ± SEM. After surgery, the animals were 
allowed to recover for 4 days at least  in the box used for recordings (Ta 25 ± 1 
°C; 12h: 12h light-dark (LD) cycle (L 09:00 to 21:00); light intensity 150 lux; 
food and water ad libitum ). In the morning of the fifth day were connected to the 
recording cable and allowed to adapt to the system of acquisition for the next 
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three days, during which recordings were made of the test to verify the correct 
operation of the sensors and to choose the derivation electroencephalography to 
acquire.
3.1 SURGERY
3.1.1 PREPARATION OF ELECTRODES
Before each surgical session, electrodes for the chronic recording of the 
electroencephalogram (EEG), nuchal electromyogram (nuEMG), diaphragmatic 
electromyogram (diEMG) and a thermistor for the recording of the hypothalamic 
temperature (Thy) were assembled. For the EEG electrodes, two copper wires 
with a length of 2 cm and a diameter of 0.3 mm coated with an insulating film 
were used. The insulating film on each free-end of each copper wires was 
removed for 1 mm. The EMG electrodes were constructed from pairs of wires of 
stainless steel (model AS 632, Cooner Wire Inc., Chatsworth (CA), USA) coated 
with an insulating sheath of polyethylene, with a length of 15cm (diEMG) or 8cm 
(nuEMG), to which were removed 3mm insulating sheath at the ends, and 2mm of 
sheath at mid-length of the cable. 
3.1.2 THERMISTORS
For the measurement of the hypothalamic temperature (Thy), thermistors 
embedded in glass gob (NTC Thermometrix) diameter of 0.3mm were used. The 
thermistors have been inserted into the tip of a needle 21 G and connected to a 
spinet two-pin placed in the neck of the needle connection; the whole was 
insulated with several layers of paint for electrodes.
On the day preceding the surgery the thermistors were subjected to a 
calibration procedure during which it was evaluated the constancy of the physical 
characteristics of the transducer, and it proceeded to the same linear calibration. 
To do this, the thermistor was immersed in a large container of water (thermo 
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bath) brought to a temperature of 39 ° C, measured by means of a mercury 
thermometer (scale 34 ° C-42 ° C), and connected to current amplifier that would 
be used during the following days to the animal.
To evaluate the constancy in time of the physical characteristics of the 
thermistor, it the mass of water was let to cool spontaneously. To compare the 
operation of the thermistor to different times of use, the impedance was measured 
at three temperatures: 38.5 ° C, 37.5 ° C and 36.5 ° C.
3.1.3 SURGICAL INTERVENTION
After 7 weeks of adaptation to the laboratory conditions and feeding 
animals which were fed either the HC or the NC diet were selected for the 
experimental procedures. Animals underwent surgery under general anesthesia 
(Preanesthesia: Diazepam, Valium Roche, 5 mg / kg intramuscularly; Anesthesia: 
Ketamine-HCl, Parke-Davis, 100 mg / kg intraperitoneally.) For implantation of 
the apparatuses for recording physiological parameters, the animal were shaved on 
the head, the chest area corresponding to the xiphoid process and the abdominal 
area along the line formed between the abdominal muscles and the hind leg.
All the shaved areas have been disinfected with Betadine for surgical use 
in order to avoid bacterial contamination during the operations. In the abdominal 
area, between the abdominal wall and the hind leg, a cut of about 2 cm of the skin 
and the subcutaneous tissue has been practiced to expose the femoral artery, 
which has been detached from the connective tissue surrounding the femoral vein 
that runs adherent to it. A small incision was then made by a scissors in the artery 
where the catheter was inserted in order to measure the changes in the arterial BP 
in the abdominal aorta. The telemetric BP transducer (TA11PA-C40, DSI) 
connected to the catheter was housed and fixed subcutaneously in the abdominal 
wall. Before the operation of catheterization, the catheter has been suitably 
sterilized by placing it for about ten minutes in a sterilizing solution (NU-CIDEX 
NCX010, Johnson&Johnson).
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For the implantation of electrodes for recording of diaEMG, two incisions  
have been practiced, one at chest level of the xiphoid process, the other at the 
level of the skull; the xiphoid process was then grasped with forceps and folded to 
upward in order to expose the underlying diaphragm: there, by means of a suture 
needle, electrode wires were inserted into the muscle. At this point by means of a 
lead plastic tube, electrode wires were passed subcutaneously in the chest area up 
to the skull, where the two ends of each of the two wires were joined and 
connected to a connector. The incision made at the level of the skull was also used 
to access the nuchal muscles, passes through which, by means of a suture needle, 
were inserted into the muscle and scroll to bring the central part, unsheathed, in 
direct contact with the muscle tissue.
The animal was then placed on a stereotaxic apparatus (Kopf Instruments) 
(bar stops snout 3.8 mm) and after removing the periosteum were charged in the 
following order: four craniotomies (0.5mm diameter) at the periphery of the 
operative field that are served for insertion of fastening screws, a craniotomy 
(diameter 0.5) adjacent to the bregma for the insertion of the hypothalamic 
thermistor, two craniotomies (diameter 0.3mm) one on the frontal bone (-3mm 
anteroposterior (AP) 2mm Latero Lateral (LL ) from bregma) and one parietal 
bone (AP 4mm, 2mm LL from bregma) for the insertion of two electrodes aimed 
to determining the EEG . All connectors were finally anchored to the skull with 
acrylic resin (ResPal cold). At the end of the surgical procedures, for disinfection 
of abdominal wounds, Betadine (10% Betadine gel Meda Pharma Milan) for 
surgical use was applied followed by intramuscular administration of broad-
spectrum antibiotic (108,000 IU Benzilpennicillina, 2.4 mg Neobicina), to prevent 
post-surgical infections, and subcutaneous administration of 5ml of saline 
solution, in order to rehydrate the animal. Finally, the animal was kept under 
observation until the appearance of the first signs of recovery from general 
anesthesia and then was placed in its cage allowing for a week to recover from 
surgery. Two days before the experimental session each animal was connected to 
the cables for recording of physiological variables in order to allow their 
adaptation to the experimental conditions.
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3.2 APPARATUS FOR THE RECORDING
3.2.1 RECORDING BOX
The cage containing the animal was placed inside a freezer box that has 
been modified to be able to control efficiently the ambient temperature. This 
control takes place by means of a thermostat which is connected to the 
compressor of the freezer and a heater placed inside the latter. When the 
temperature deviates from the one set by the operator, the thermostat switches on 
the compressor or the heater (Vortex Microsol 600) for correcting the variation of 
temperature. The box is also equipped with: a ventilation system, an illumination 
system by means of optical fibers (100 lux at the level of the cage), and a 
telemetry receiver for recording of blood pressure of the animal, a video system 
that allows the study of the animal behavioural and a swivel for recording 
physiological variables.
3.2.2 AMPLIFIERS AND SIGNAL ACQUISITION
All bioelectrical signals recorded from the animal were amplified (Grass 
mod. 7P511L, Astro-Med, West Warwick (RI), USA) and filtered, respectively, 
for the low-pass and high-pass filter, with the following values for each variable: 
EEG 0.3 Hz / 30 Hz, nuEMG 10 Hz / 3000 Hz, diEMG 100 Hz / 1000 Hz and 0.5 
Hz Thy. Following all the signals have undergone an analog-digital conversion to 
12-bit (CED Micro 1401 MK II) to be stored on a computer-readable form (PC 
ASUS) with a sampling frequency of 500Hz for the EEG, of 1KHz for the 
nuEMG and of 50 Hz for Thy. The cages, at their top, were also equipped with a 
holder for passive infrared motion detector (PID20, Siemens). This sensor was 
oriented for maximum sensitivity of the movements of the animal. During the 
experimental sessions, was possible to monitor the behaviour of the animals 
thanks to a closed-loop system (Philips), consisting of two monitors in black and 
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white connected to a camera positioned inside the box of recording in 
correspondence of the two cages.
The electroencephalographic signal has been subjected to a spectral 
analysis using the algorithm of the Fourier transform (FFT) on a sliding (1 
second) window  of 4 seconds in order to obtain the values of power density for 
the bands Delta (0. 5-4 Hz), theta (5.5-9 Hz) and Sigma (11-15 Hz). The signal of 
the PA was recorded telemetrically, amplified (DSI Phyiotel PA-C40, 
DataSciences) and incorporated digitally on a PC with an acquisition frequency of 
500 Hz.
3.3 EXPERIMENTAL DESIGN
3.3.1 STUDY OF WAKE-SLEEP BEHAVIOR AND AUTONOMIC 
FUNCTION IN ANIMALS FED WITH HYPERCALORIC DIET FOR 8 
WEEKS
At their arrival, animals were randomly assigned to the NC or the HC 
experimental group. At the seventh week of the treatment, the selection of the NC 
diet-fed animals which underwent surgery and entered the experiment (n=8) was 
made randomly. Since about 50% of Sprague-Dawley rats fed a HC diet are 
apparently resistant to obesity and obesity comorbidities development (Levin et 
al., 1983), the selection of animals (n=8) for the HC experimental group was 
made randomly among those whose weight, at the moment of the selection, was 
over the median value of the population. 
After at least seven days of recovery from surgery and of adaptation to the 
recording chamber, animals were recorded for four consecutive days: Day 1 and 2  
for the baseline (BL1 and BL2, respectively); Day 3, which was divided in two 
halves; 12-h sleep deprivation (SD), from 09:00h till 21:00h (sleep deprivation 
was carried out manually by the gentle handling of animals, immediately after 
EEG signs of NREMS were detected) and 12-h recovery, for the rest of the day 
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(R0, 21:00h – 09.00). The whole Day 4 was aimed at monitoring the completion 
of the recovery from sleep deprivation (R1). 
In all groups the baseline recordings under normal laboratory conditions 
(BL1 and BL2) were preceded by a day of trial recording, aimed at verifying the 
good functionality of the recording apparatus. The beginning of each day's record 
(09.00 h) was made to coincide with the light-on time of the normal light-dark 
cycle. In every day, 15 minutes after illumination of the lamp in the box have 
been constantly employed for the cleaning of the cages and the control of correct 
acquisition of data relating to the previous day. The animals were recorded in 
pairs, and had been used two boxes of recording. For each group the experiment 
was conducted always in parallel between two animals NC and two animals HC. 
Every couple underwent the recording session individually in a separated 
lab to prevent any effect on the results of the counterpart animal. The recordings 
in the two different boxes alternated between NC and HC animals. 
Due to e major problem in the EEG signal, one NC animal has been 
excluded from the experiment. Therefore data relative to only 7 NC animals will 
be presented.
3.3.2 DATA COLLECTION
Scoring of S-W episodes and analysis of the arterial blood pressure signal 
were conducted as hereafter: a visual scoring of wake-sleep states were performed 
on all consecutive 4-s epochs based on EEG and EMG signals. Inter-peak interval 
between two consecutive pressure pulse was used to derive the heart rate (HR).
Extreme attention was placed in the determination of the sleep 
microstructure, especially in the discrimination of REMS episodes between single 
REMS episodes (separated by long REMS intervals, > 3 min) and sequential 
REMS episodes (separated by short REMS intervals, <= 3 min ), according with 
previously published methods (Amici et al., 1994). 
Differentiation between the different wake-sleep stages were done offline 
using Spike-2 (CED) software based on the measured parameters. The data were 
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then filtered using custom software developed in LabView 6i (National 
Instruments) in order to remove the artefacts. By this software we were able to 
average each parameter in 30 minutes windows.
Through this type of analysis it has been possible to study the following 
variables: i) The total amount of Wake, NREMS, REMS, Sequential and Single 
REMS; ii) Number and duration of Sequential and Single REMS episodes; iii) 
Power density of the Delta and Sigma bands in NREMS, and the Theta band in 
REMS; iv) Hypothalamic temperature during the different wake-sleep states v) 
Systolic, diastolic and mean arterial BP and HR during the different W-S states.
The data collected from the diaphragmatic EMG are still under analysis 
and will not be shown in this thesis.
3.3.3 STATISTICAL ANALYSIS
Statistical analysis was carried out by ANOVA (SPSS 9.0).  A number of 
pre-planned orthogonal and non-orthogonal contrasts were made by means of the 
modified t-test (Winer, 1971). For the non-orthogonal contrast the alpha level was 
adjusted by the “sequential” Bonferroni correction (Holm, 1979). 
Two-way ANOVA for repeated measures on one factor was used, with 
either a 24-h, or a 12-h, or a 2-h resolution according to the different parameters 
analyzed. 
In particular, for the 24-h resolution analysis were considered as Main 
Factors: i) Factor “Time”, which was considered for the repeated measures, with 
four levels  (Day 1 -4); ii) Factor “Diet” with two levels (NC, HC). The following 
orthogonal contrast [NC-BL1; NC-BL2] vs. [HC-BL1; HC-BL2], aimed at 
comparing NC to HC was carried out. 
For the 12-h resolution analysis were considered as Main Factors: i) Factor 
“Time”, which was considered for the repeated measures, with eight levels (BL1-
L, BL1-D, BL2-L, BL2-D, SD-L, R0-D, R1-L, R1-D); ii) Factor “Diet” with two 
levels (NC, HC). Orthogonal contrasts were carried out aimed at comparing NC to 
HC values, while non-orthogonal contrast were carried out aimed at comparing: i) 
67
L to D values within the Baseline (BL1, BL2) and within R1; ii) each 12-h L or D 
value of Day 3 or Day 4 to the corresponding L or D level of the Baseline (Day 1-
2). In particular, the following orthogonal contrasts: i) [NC-BL1-L, NC-BL2-L] 
vs. [HC-BL1-L, HC-BL2-L]; ii) [NC-BL1-D, NC-BL2-D] vs. [HC-BL1-D, HC-
BL2-D]; iii) [NC-SD-L] vs. [HC-SD-L]; iv) [NC-R0-D] vs. [HC-R0-D]; v) [NC-
R1-L] vs. [HC-R1-L]; vi) [NC-R1-D] vs. [HC-R1-D]; and the following non-
orthogonal contrasts: i) [NC-BL1-L; NC-BL2-L] vs. [NC-BL1-D, NC-BL2-D]; ii) 
[HC-BL1-L; HC-BL2-L ] vs. [HC-BL1-D, HC-BL2-D]; iii) [NC-R1-L] vs. [NC-
R1-D ]; iv) [HC-R1-L] vs. [HC-R1-D ]; v) [NC-BL1-L; NC-BL2-L ] vs. [NC-
SD- L]; vi) [HC-BL1-L; HC-BL2-L ] vs. [HC- SD- L]; vii) [NC-BL1-D; NC-
BL2-D ] vs. [NC- R0- D]; viii) [HC-BL1-D; HC-BL2-D ] vs. [HC- R0- D]; ix) 
[NC-BL1-L; NC-BL2-L ] vs. [NC- R1- L]; x) [HC-BL1-L; HC-BL2-L ] vs. [HC-
R1-L]; xi) [NC-BL1-D; NC-BL2-D ] vs. [NC-R1-D]; xii) [HC-BL1-D; HC-BL2-
D ] vs. [HC- R1- D], were carried out.
For the 2-h resolution analysis were considered as Main Factors: i) Factor 
“Time”, which was considered for the repeated measures, with 48 levels (2h * 4 
Days); ii) Factor “Diet” with two levels (NC, HC). Orthogonal contrasts were 
carried out aimed at comparing NC to HC values for each 2-h time interval, while 
non-orthogonal contrast were carried out aimed at comparing: i) L to D values 
within the Baseline (BL1, BL2) and within R1 for each 2-h time interval; ii) each 
2-h value of Day 3 and Day 4 to the corresponding 2-h level of the Baseline (BL1, 
BL2).  
The weights of the animals were statistically analyzed by one-way 
ANOVA.
Throughout all analyses, differences were considered statistically 
significant when P<0.05.
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4.Results
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4.1. BODY WEIGHT
As shown in Fig. 3, after 8 weeks of treatment the weight of the animals 
was higher in the HC group than in the NC group (HC, 557±17 g; NC, 441±17 g; 
p<0.05). At the seventh week, the weight of the animals that have been selected in 
the NC group was 420±12g and it was not different from that of those that were 
not selected, i.e. 436±15. On the contrary, the weight of the animals that were 
selected in the HC group was 516±18g, significantly different from that of those 
that were not selected, i.e. 442±10. The latter rats were not heavier than those of 
the NC group, confirming that only about 50% of animals fed a HC diet develop 
obesity.
4.2 ANALYSIS OF THE WAKE-SLEEP STATES UNDER 
BASELINE CONDITIONS
As shown in Fig. 4, the proportion between the amount of Wake and Sleep 
was different in the two experimental groups when analyzed on a 24-h time scale. 
In particular, in the NC group the amount of Wake was largely over the 50% of 
total time and it was significantly higher than in the HC group (p<0.05). 
Therefore, reversely, the amount of total sleep was lower in the NC than in the 
HC group. In particular, the amount of both NREMS and REMS was significantly 
larger in the HC group compared to the NC one, although only for NREMS the 
statistical significance was reached (p<0.05). 
The analysis of this parameter was also carried out on a 12-h time scale 
and is shown in Fig. 6. The distribution of the W-S states followed the normal 
Light-Dark (LD) pattern, since in the NC group the amount of Wake (and, 
reversely, the amount of total sleep) was significantly larger during the D period 
(p<0.05) than during the L period, confirming that the rat is more active during 
the D hours. This pattern was maintained in the HC group, although it was largely 
dampened due to a specific significant depression of Wake occurrence during the 
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D hours (p<0.05), with no differences with the NC group in the L hours. The 
reverse was observed for both NREMS and REMS, since the HC animals slept 
more than the NC animals during the D hours (p<0.05, for both) In particular, the 
increase of REMS occurrence was so large that the normal LD distribution of this 
sleep stage disappeared.
The analysis of the partition of REMS in Single REMS (episodes which 
are both preceded and followed by a long REMS interval, > 3min) and Sequential 
REMS (episodes which are preceded and/or followed by a short REMS interval, 
<= 3min) showed that the increase of REMS during the D hours was mostly due 
to a significant increase in Sequential REMS (p<0.05). This effect was 
accompanied by the disappearance of the normal LD distribution of Single 
REMS). 
A more detailed analysis on the number and duration of Single and 
Sequential REMS episodes is shown in Fig.7. Still, the effect of HC diet delivery 
was on Sequential REMS, leading to an increase in the number of Sequential 
REMS episodes (p<0.05) during the D hours, with almost no effects on the 
duration of the episodes. Also, the normal LD distribution of Sequential episodes 
disappeared in the HC group.
4.3 ANALYSIS OF THE AUTONOMIC PARAMETERS UNDER 
BASELINE CONDITIONS
As shown in Fig.9, major changes were observed on a 24-h basis on the 
cardiovascular parameters which were taken into account. In particular, the HC 
animals showed to be hypertensive when compared to the NC ones, since the 
average 24-h mean arterial BP significantly (p<0.05) increased from 88.7±5.2
mmHg to 95.9 ±1.2 mmHg. The opposite was observed for average HR, which 
was slightly but significantly (p<0.05) lower in the HC group (350 ± 9) than in the 
NC group (343 ± 7 bpm). No relevant changes were observed in the average Thy 
levels.
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These changes were substantially confirmed by the 24-h state-dependent 
analysis of the three parameters (Fig.10). In particular, mean arterial BP was 
significantly higher (p<0.05) in each of the three W-S states in HC than in NC 
animals. HR was also lower in each of the three states in the HC animals, but the 
difference reached the statistical significance only during Wake (p<0.05). Again, 
non changes were observed in Thy. 
A more detailed analysis of the autonomic parameters was carried out on a 
12-h LD time scale. In NC animals, Thy levels showed the normal LD cyclic 
pattern, with higher values during the D hours in each W-S state. This oscillation 
was confirmed in HC animals, but for REMS, where the oscillation was not 
statistically significant. It is worth noting that this effect was concomitant with the 
large aforementioned increase in REMS occurrence during the D period. 
Average systolic, diastolic and mean arterial BP were significantly higher 
(p<0.05 for all comparisons) in HC animals compared to NC ones in each of the 
three W-S states. Furthermore, a significant LD oscillation appeared in HC 
animals in systolic, diastolic and mean arterial BP in Wake and in systolic and 
diastolic arterial BP in NREMS, with higher levels during the D period, which 
was not observed in NC animals. Concomitantly, HR levels were significantly 
lower (p<0.05) during Wake and REMS in the D period only in the HC group, 
while a not significant decrease was also observed in NREMS.
4.4 ANALYSIS OF THE WAKE-SLEEP STATES DURING THE 
12-h PERIOD OF TOTAL SLEEP DEPRIVATION AND IN THE 
FOLLOWING RECOVERY PERIOD
The analysis of the W-S states during the 12-h period of total sleep 
deprivation by gentle handling and in the following period of recovery (R0, which 
corresponds to the D period of the same experimental day (Day 3) in which the 
deprivation has been carried out, and R1, which is the following experimental day 
(Day 4) is shown with a 12-h time scale in Fig. 16. 
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The analysis of the results showed that during the period of sleep 
deprivation Wake didn’t reach the 100%, as may be expected. This depend on the 
fact that in order to minimize the stress of the animal due to the manipulation to 
keep it awake, the intervention of the experimenter only follows the first signs of  
NREMS. On this basis, as expected a few NREMS, but no REMS, was observed 
during the SD period. REMS was not observed since, of course, some NREMS is 
necessary for REMS to occur, and the intervention of the experimenter was 
always quick enough after the start of a NREMS episode to prevent the 
occurrence of REMS. 
The results showed that, as expected, in the NC group the amount of Wake 
was lower during R0 than during the corresponding D period of BL (p<0.05), 
while no significant post effects were observed during R1, suggesting that the 
most of the expected sleep rebound occurred during R0. This pattern was 
reproduced in the HC group, in which the amount of Wake was significantly 
lower (p <0.05, for all comparisons) than in the NC group not only during the D 
period of BL (as already described), but also during both R0 and the D period of 
R1. Reciprocal results were observed for both NREMS and REMS, although the 
REMS rebound during R0 was not significantly larger in HC than in NC. 
The analysis of the partition of REMS in Single and Sequential REMS 
(Fig. 17) clearly indicated that REMS rebound occurred under the form of 
Sequential REMS in both NC and HC animals, while no rebound of Single REMS 
was observed. The Sequential REMS rebound was large and significant during R0 
in both groups (p<0.05, for both), but reached the statistical significance during 
the L period of R1 for NC animals only, while the amount of Sequential REMS 
amount was significantly lower (p <0.05) in the HC group compared to the NC 
group in the L period of R1.
The detailed analysis of the number and duration of Single and Sequential 
REMS episodes (Fig. 18 and 19, respectively) showed that the REMS rebound
occurred substantially through and increase in the number of Sequential REMS 
episodes in both experimental groups, while no substantial changes in the number 
of Single REMS episodes were observed. The pattern of changes in the number of 
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Sequential REMS episodes overlapped even in statistical terms that of the amount 
of Sequential REMS. Minor changes, although statistically significant (p <0.05),  
in the duration of Sequential REMS episodes were observed in both groups during 
R0 only, while a little increase in the duration of Single REMS episodes was 
observed in NC animals only.
The analysis of the dynamics of the sleep rebound process is shown for 
NREMS and REMS in Fig. 20 and 21, respectively, in which the cumulative 
amount of both sleep states across the experimental sessions is shown. Data are 
shown as the accumulation of 12-h period amounts which are expressed as the 
percent of the 24-h baseline value (which is therefore taken as 100%). No 
substantial differences in the accumulation of NREMS were observed in the two 
groups. The actual loss of NREMS during SD was 53.4% of daily amount for NC 
animals and 52.4% of daily amount for HC animals, while the cumulative amount 
of the SD_R0 and R1 Days, which was expected to be 200% in the absence of any 
deprivation, was actually 162.3 ± 5.3% for NC animals and 165.4 ± 3.8 for HC 
animals, showing a weak NREMS rebound in both groups.
For what concerns REMS, the loss was of 59.6% and 49.1% for NC and 
HC animals, respectively. For both the cumulative amount of the SD_R0 and R1 
Days, which was expected to be 200% in the absence of any deprivation, was 
actually close to 200%, since it was 197.7 ± 11.0 % for NC and 191.5 ± 11.9% in 
NC and HC animals respectively, showing an almost complete REMS rebound in 
both groups. The dynamics of the process underlying the REMS rebound 
appeared to be faster in the NC group, since a statistically significant (p<0.05) 
larger accumulation of REMS was observed in NC at R1_L.
The study of the dynamics of the sleep rebound has been completed by the 
analysis of the time course of Delta and Sigma Power in NREMS (Fig. 22) and 
Theta Power in REMS (Fig. 23). The dynamics of Delta Power followed a similar 
pattern in NC and HC animals. As it may be expected, Delta Power increased 
largely over the baseline values in the NC group in the few NREMS episodes 
which occurred during the last two hours (p<0.05) of the sleep deprivation 
process, when a sleep debt had already been accumulated. The peak in Delta 
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power occurred during the first two-four hours of the recovery period (p>0.05) 
and progressively decreased to normal levels at the end of R0, returning to 
baseline levels in R1. A similar pattern was observed for HC animals, even if the 
increase in Delta Power during sleep deprivation was observed two hours in 
advance and was significantly different form baseline levels only in the first two 
hours of R0. No significant differences in the dynamics were observed between 
the two groups.
Similarly, the profile of Sigma Power, which typically showed a clear LD 
oscillation in the baseline, was clearly shifted towards higher level with the 
progression of the deprivation and during the initial part of the recovery. 
However, apparently due to the large variability  of data, the difference with the 
baseline was significant only during the third 2-h interval on R0 in the HC group. 
Still, no significant differences in the dynamics of the process were observed in 
the two experimental groups.
Also for Theta Power in REMS, no significant difference were observed 
between the two groups. The expected increase in Theta Power during the initial 
R0 was not large enough to reach a statistically significant level. 
4.5 ANALYSIS OF THE AUTONOMIC PARAMETERS 
DURING THE 12-h PERIOD OF TOTAL SLEEP 
DEPRIVATION AND IN THE FOLLOWING RECOVERY 
PERIOD
Hypothalamic temperature levels were similarly affected by the 
manipulation of the animals in both groups, since Thy was largely increased 
during the induced Wake in SD (p<0.05, for both) and even in the few NREMS 
episodes which occurred during SD (p<0.05, for both). However, the effect of the 
manipulation on this parameter appeared to be more intense in the HC group than 
in the NC group during NREMS (p<0.05). The pattern of Thy levels was similar 
77
in the two groups also during the Recovery period, however Thy in NREMS 
remained larger during R1_D in the HC group (p<0.05). 
For what concerns the mean arterial BP levels, an increase in this 
parameter was observed during SD in the NC animals in both Wake and NREMS 
compared with the L period of the baseline (p<0.05, for both). These values 
returned to baseline levels in R0 and even to levels lower than those of the 
baseline during R1_D in each of the three W-S states (p<0.05, for all 
comparisons). The increase in mean arterial BP levels in Wake and NREMS 
during SD was observed also in the HC group (p<0.05 for both). Furthermore, HC 
animals showed higher arterial blood pressure values than NC animals throughout 
the experiment and in each of the W-S states (p<0.05, for all comparisons). 
Interestingly, the aforementioned arterial blood pressure drop during R1_D was 
not present in HC animals.
Finally, in NC animals the pattern of changes in HR practically overlapped 
with that observed for arterial BP, although the fall during R1_D compared to the 
D period of the baseline was significant only during NREMS and REMS (p<0.05 
for both). Differently from what observed for mean arterial BP, the fall in HR was 
also observed in HC animals in NREMS and REMS (p<0.05 for both). 
Furthermore, heart rate was significantly lower in HC animals than in NC animals 
during R0 throughout the W-S states (p<0.05, for all). The statistical significance 
of the difference between NC and HC levels disappeared during R1, possibly due 
to the evident drop of HR observed in the NC group. 
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5.Discussion
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The results of the present study indicate that, in the rat, the long-term 
administration of a high-energy hypercaloric diet leading to the development of a 
frank diet-induced obesity (DIO) produces relevant changes in the W-S pattern 
and leads to a consistent increase in the arterial BP levels which persisted in each 
of the three W-S states (Wake, NREMS, REMS).
The selection of the animals may have introduced some bias, since it is not 
possible to distinguish among obesity prone (OP), which will become obese when 
fed a HC diet, and obesity resistant (OR) rats, which will not develop obesity,
before the long-term delivery of the HC diet (Levin et al., 1983, 1997). On this 
basis, the selection of NC animals was made randomly, and, possibly, a 50%/50% 
of obesity prone (OP) and OR rats may have been selected. On the contrary, the 
HC animals which were selected for the study were among those over the median 
weight of the HC population after 8 weeks of treatment, and therefore within 
those which could be actually classified among DIO rats. In spite of this, since the 
authors who studied the DIO rat model stated that clear differences in metabolic 
and brain functions between OP and OR rats only emerged after a long-term 
delivery of the HC diet or after the development and perpetuation of the genetic 
traits of the two populations following selective inbreeding (Levin et al., 1998), it 
can be assumed that NC animals that were used in the present study constituted a 
reasonably good control group for obese animals. Also, the possibility to use 
animals that didn’t gain weight after HC diet delivery as a control group was 
discarded due to the fact that it couldn’t be excluded that the absence of weight 
gain came from the sufferance of the animal from any kind of injury different 
from being OR Furthermore one major determinant of the development of DIO is 
the increase in energy intake that was observed in OP rats compared to OR ones 
when exposed to the HC diet, which is much more palatable (Levin et al., 1983). 
Although other autonomic and metabolic determinants has been indicated, in 
particular after selective inbreeding (Levin et al., 1997), the largest difference 
between OP and OR animals comes from the amount of HC food ingested. 
Therefore, OR animals couldn’t fully match HC animals.
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The results of the present study clearly indicate that the 24-h total sleep 
time is increased of about 10% in HC animals compared to NC ones. The effect is 
mostly due to a large increase in both NREMS and REMS during the activity 
period (that is the D period) of the normal LD cycle, leading to a disappearance of 
the normal LD oscillation of REMS occurrence.  
An effect on the W-S pattern, mostly consistent in an increase in sleep 
occurrence has been observed in several rodent models of obesity previously 
studied. However, the outcome from different studies are slightly different, in 
particular when results obtained in rats are compared to those in mice and when 
the effects observed in animals which have been made obese by a HC diet 
delivery are compared to those observed in animals made obese by interfering 
with the normal function of the leptinergic system. 
The W-S pattern after the development of obesity following the 
administration of a HC diet have been consistently studied in mice only, which 
were made obese by a 2-10 week HC diet administration (Jenkins et al., 2006; 
Guan et al, 2008). In the study by Jenkins, total sleep was observed to be 
increased mostly during the D period of the LD cycle, but this was due to an 
increase in NREMS without any effect on REMS. The weak or absent effects on 
REMS were confirmed by Guan, since a significant, but transient, increase in 
REMS occurrence accompanied the consistent increase in NREMS only in one of 
the two experimental groups studied. On the overall, some dampening in the 
normal LD distribution of activity and rest was observed, but not in that of REMS. 
The only two studies in which a HC diet has been delivered to a rat are a 
pioneering research by Danguir (1987) and a more recent study by Laudadio 
(2010). In the first study, an increase in both NREMS and REMS were observed 
after just 10 days of HC diet delivery, well before the development of a frank 
obesity, while in the second (which was part of a PhD thesis; data have still not 
been published on the international literature) an increase in the total amount of 
sleep was observed after 8 weeks of HC diet delivery, that was mostly explained 
by an increase in the amount of REMS. An overall tendency to sleep enhancement 
during the D period was observed.
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In other studies, the W-S states have been analysed in animals in which 
obesity was developed by genetic manipulations aimed at interfering with the 
leptinergic signalling. With respect to this, mice have been deprived of the ability 
to produce leptin (ob/ob mice) or have become resistant to the action of the 
hormone itself through the induction of a mutation of the hypothalamic receptor 
for leptin (db/db mice). The ob/ob mice, showed an increase in NREMS amount, 
mostly during the D period, but no changes in the total amount of REMS, with a 
significant attenuation of the amplitude of the normal LD distribution of NREMS 
and REMS compared to their controls (Laposky et al., 2008; Silvani et al. 2009), 
due to a redistribution of sleep states between L and D. Similar results were 
observed in db/db mice (Laposky et al., 2008), which even showed a concomitant 
reduction of the 24-h amount of REMS. Studies on rats have been carried out on 
Zucker fa/fa animals, which lack leptin receptors, which showed either an 
increase in NREMS (Danguir et al., 1989), with no effects on REMS sleep and 
LD distribution of W-S states, or even no effects on the amount of sleep 
(Megirian et al. 1998).
Thus, from one side it seems that, in mice, the development of obesity has
prevalent effects on NREMS enhancement, mostly during the D period, and is 
accompanied by a weak enhancing effect on REMS in HC-diet delivered animals 
only. No major effects on REMS amount was observed in leptin-absent or leptin-
resistant animals, in which the only effect on REMS was the dampening of the 
daily REMS oscillation. From the other side, in the rat, studies on HC diet-
delivery leading to obesity are missing or still unpublished, but suggest an 
enhancing effect of DIO on sleep occurrence, and in particular on REMS, while 
studies on leptin-resistant animals indicate an inconsistent increase in NREMS 
only. 
Therefore, the present study supports the studies on mice, which showed 
the tendency of the animal to sleep more during the normal activity period after 
the development of obesity, but also shows that, differently from what observed in 
ob/ob and leptin-resistant mice, the increase in REMS occurrence during the D 
period was not accompanied by a decrease in REMS occurrence during the L 
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period and therefore, even if in the present study the increase in REMS did not 
reach the significance level on a 24-h time scale, it can be concluded that REM
sleep enhancement during the activity D period is not explained by its depression 
during the rest L period. 
The results of the present study therefore support those from studies in 
obese humans (Vgontzas et al. 1998), which suggest that the tendency of obese 
humans to sleep more during the day cannot be only explained on the basis of the 
sleep disruption during the night (which usually depends on the development of 
an obstructive sleep apnea syndrome in the obese, leading to sleep fragmentation), 
but appears to be more related to a metabolic and/or circadian abnormality due to 
the disorder. This finding underlines the need for the development of a reliable 
animal model of DIO, in order to develop further physiological studies aimed at 
addressing and clarifying these issues.
The analysis of the partition of REMS in Single and Sequential REMS 
clearly indicated that REMS enhancement during the D period was the effect of 
an increase in Sequential REMS, due to an increase in the number of Sequential 
REMS episodes. This finding fully confirm that the occurrence of Sequential 
REMS is the modality through which REMS occurrence is physiologically 
modulated in the rat when the animal has to produce more REMS, e.g. to 
compensate for a previous REMS deprivation, or to cope with environmental 
conditions which are known to induce either a suppression or an enhancement of 
REMS occurrence (Amici et al., 1994, 1998; Zamboni et al., 2001; Cerri et al., 
2005). The production of Sequential REMS, in which the REMS episodes occur 
in rapid sequence within a cluster, is considered to be safer for the animal, since it 
allows him to produce longer REMS episodes with brief interruptions, in which 
the possibility to prolong the episode may be checked (Amici et al., 1994). In fact, 
physiological regulation during REMS has been shown to shift from a full 
homeostatic to a poikilostatic modality (Parmeggiani, 2005), during which the 
suspension of the homeostatic control of body temperature represents the main 
feature. On this basis, it may be assumed that the brief interruptions within REMS 
episodes allow the animal to check whether the level of the physiological 
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variables still fit the “safety” requirements for a further prolongation of the REMS 
episode. Thus, the fact that REMS enhancement in the obese rat is modulated 
through the modality which is commonly observed in this species suggests that 
such an enhancement represents a specific physiological need for the obese animal 
and that such REMS would be part of a quota that would be defended and, 
therefore, recovered following sleep deprivation. 
The observed increase in NREMS and REMS in the obese animal is 
difficult to interpret, mostly due, of course, to the poor knowledge of sleep 
functions. For sure, it cannot be considered to be a mechanism aimed at energy 
saving, since this would go in the opposite direction with respect to the metabolic 
needs of the animal. More reliably, it may be assumed that metabolic signals 
coming from the energy deposits operate at hypothalamic level within the neural 
network where the control of W-S states and the regulation of food 
intake/metabolism overlap. With respect to this, possible targets of this overlap 
could be the hypocretinergic (HCRT) neurons of the lateral hypothalamus which 
are known to promote both active Wake and food intake (Sakurai et al., 2011). 
The activity of HCRT neurons has been shown to be inhibited by both glucose 
(Burdakov et al., 2006) and leptin (Wynne et al., 2005). In other terms, it may be 
assumed that in the presence of a large energy store and, consequently, of high 
circulating leptin levels, there would be no need for the animal to be active for 
foraging. 
The analysis of the sleep pattern during the recovery period which 
followed sleep deprivation showed the absence of major differences in the 
dynamics of both NREMS and REMS rebound between obese and lean animals. 
From one side, this indicates that the brain mechanisms underlying sleep 
homeostasis are not altered in obese animals. Since the control of these 
mechanisms is largely attributed to different hypothalamic structures mostly at 
preoptic level (Szymusiak et al., 2007), it appears that the functional alteration in 
the metabolic function of the obese animals doesn’t interfere with these structures. 
With respect to this, it has to be reminded that the REMS rebound which follows 
REMS deprivation has been shown to be largely depressed when the cellular 
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activity is functionally impaired at preoptic-hypothalamic level, in regions 
involved in the regulation of both sleep and body temperature/metabolism 
(Zamboni et al, 2004).
From the other side, the presence in the HC animals of a sleep rebound the 
intensity of which substantially overlap that observed in NC animals also in terms 
of the amount of sleep recovered calculated as the percent of sleep produced under 
baseline conditions, clearly indicate that sleep produced by the HC animals is 
defended and normally recovered following a challenge which leads to its loss. It 
is known that REMS is precisely homeostatically regulated in terms of its amount 
in different species (Parmeggiani et al., 1980; Cerri et al, 2005; Amici et al, 
2008). In particular, in the rat a fast rebound is observed following deprivation in 
which the urgent need of REMS is satisfied, which is followed by a slow 
(probably less urgent) rebound, which leads in few days to a 100% recovery of the 
REMS loss. In the present experiment, the fact that both NC and HC animals 
practically fully recover the REMS loss in less than two days, suggests that the
apparent excess of REMS produced during the D period by the HC animal when 
compared to the NC one cannot be “used” by the animal to buffer the previous 
loss. In other words, this excess of REMS is not part of what has been previously 
described as “facultative” REMS in the cat (Parmeggiani et al., 1980).
Also the dynamics of the NREMS rebound, which usually occurs in terms 
of an increase of NREMS intensity marked by an increase in the intensity of the 
Delta Power of the EEG, is not different in the two groups. It may be reminded 
that the absolute levels of Delta Power cannot be compared in the two groups,
since the amplitude of the EEG signal may be largely influenced in different 
animals by physical factors not linked to the real activity of the source (e.g., the 
position and deepening of the electrodes on the scalp). However, the fact that the 
proportion between the Delta Power intensity during the NREMS rebound which 
followed enhanced Wake induced by gentle handling and that observed in the 
baseline was maintained at the same level in the two groups suggests that the 
quality of Wake under baseline conditions, which is known to largely influence 
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Delta Power in the following NREMS (Tononi and Cirelli, 2003; Borbély and 
Achermann, 2005), was not substantially different between HC and NC animals.
The analysis of the autonomic parameters in the two groups has shown that 
DIO rats develop a hypertensive state, with an increase in systolic, diastolic and 
mean arterial BP that is maintained across the different W-S states during both the 
L and the D period of the LD cycle. 
Data shown in Fig 10 confirm that in the rat, as it occurs in humans, mean 
arterial BP levels changes through the different W-S states, reaching a maximum 
during Wake and a minimum during NREMS, while during REMS an increase 
towards Wake levels is observed, the degree of which is in accordance with the 
average duration of REMS episodes and the degree of phasic cardiovascular 
activations (Sei et al, 1997; Amici et al., 2013). The presence of variable changes,
in accordance to their genetic background, in mean arterial BP in the transition
from NREMS to REMS has also been shown in mice (Silvani et al., 2009; 
Campen et al., 2002). This state dependent oscillation was apparently maintained 
in HC animals, during both the L and the D period of the LD cycle. It needs also 
to be stressed that the apparently low absolute values of mean arterial BP that 
have been found in the present study in NC animals are compatible with the fact 
that, particularly in small rodents, arterial BP levels are largely influenced by the 
ambient temperature (Ta), and largely decrease when animals are kept at Tas 
ranging from 25° to 30° C (Sei et al., 1996). 
Previous observations on the arterial BP levels in obese rats are 
inconsistent. In fact, while the development of hypertension has been shown after 
8-10 weeks of administration of a hypercaloric (HC) diet (Dobrian et al., 2000), 
this observation has not been subsequently confirmed (Carroll et al., 2006).
However, in the first study, arterial BP determination was made by the tail-cuff 
method, which is not fully reliable, since the animal is disturbed during the BP 
determination, and this doesn’t allow the experimenter to make determinations 
during either quite wakefulness or sleep. In the second study, where the 
determination was made more reliably by means of a chronically implanted 
telemetric transmitter, determinations were made randomly largely independently 
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from the W-S states. The consistent increase in mean arterial BP in each W-S-
state that have been shown in HC animals in the present study, which is also 
characterized by the presence of a small variability of the parameter within obese 
subjects, makes the present observation quite reliable and suggests that frank 
hypertension develops in DIO rats, as already observed in DIO mice (Rahmouni 
et al., 2005a).
The determinants of the increase in arterial BP in obese subjects are 
multiple and are still matter of debate (Rahmouni et al., 2005b). The excess of 
leptin signalling in the obese subject is considered to be a possible determinant, 
since it has been shown that: i) leptin acts centrally as an activator of sympathetic 
nervous activity and metabolic expenditure, through brown adipose tissue 
activation (Rahmouni et al., 2005b); ii) chronic leptin i.c.v. administration induce 
hypertension and tachycardia (Shek et al., 1998). However, although it has been 
shown that DIO mice don’t develop resistance to the cardiovascular effects of 
leptin, differently form what happens for the effects on metabolism and food 
intake (Rahmouni et al., 2005a), it has also been shown that, after developing 
obesity, leptin deficient ob/ob mice are hypertensive during both Wake and 
NREMS (Silvani et al., 2008). Among other possible hypertension-inducing 
factors in the obese are: i) the activation of the renin-angitensin system by the 
release of adipocyte-derived angiotensinogen; ii) a possible excess of aldosterone 
release; iii) a decrease in the vascular responsiveness to nitric oxide, due to the 
development of endothelial lesions; these changes would lead, on the overall, to 
vasoconstriction and to an increase in renal water and sodium retention 
(Rahmouni et al., 2005b). Interestingly, since, as previously discussed, heart rate 
has been shown to increase in mice after chronic leptin administration (Shek et 
al., 1998) and mice have been shown not to become resistant to the cardiovascular 
effects of leptin, the mild but significant decrease in heart rate that was found in 
the present study would indicate that the at least part of the cardiovascular effects 
which have been observed in the present study were not leptin-dependent, or even
that the observed increase in arterial BP was not due to a generalized activation of 
the sympathetic outflow.
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Such an arterial BP dysregulation appeared to be more evident during the 
recovery day 1, since while an overall decrease of mean arterial BP accompanied
the restoration of the normal daily activity pattern animals after the prolonged 
period of sleep deprivation and manipulation in the NC, this decrease was not 
observed in obese animals. Since, on the contrary, a decrease of HR rate during 
R1 was observed in both groups, it may be assumed that while HR mirrors the 
potential decrease in sympathetic activity which would reasonably accompany the 
processes of restoration in both groups, still, the (dys)regulation of arterial BP 
appears to be relatively independent from this supposed decrease in sympathetic 
activity in the HC group and, therefore, would be determined by factors other than 
a generalized increase in sympathetic tone.
Interestingly, no significant changes were observed in the level of 
hypothalamic temperature in the different W-S states between NC and HC 
animals. This suggests that in obese animals, in which passive thermal dissipation 
is much lower than in NC animals due to both the larger body mass and the 
presence of a higher fat content, either the basal metabolism is kept at a lower 
level or thermal dissipation is enhanced by, e.g., an enhanced vasodilation of the 
heat exchangers (tail, paws).
In conclusion, the results of the present experiment indicate that in the rat 
the development of obesity deeply interfere with both W-S and cardiovascular 
regulation and that diet-induced obesity rats represent a very good model to be 
used in order to go deeper in the understanding of the disturbances of the W-S
activity and of the cardiovascular comorbidities which accompany the 
development of obesity in humans.
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6. Figures
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Figure 1. Schema of surgical cranial implant. Dorsal view of the rat's skull that 
shows the points where craniotomies were made during surgery on animals under 
general anesthesia. Four screws have been placed (purple) to anchor the implant, 
two in the anterolateral portion of the frontal bones, two in the posterolateral 
portion of the parietal bones; Two electrodes for detection of the 
Electroencephalographic signal (EEG; corss), one at + 3.00 mm anterior and at + 
3.00 mm lateral to bregma, one in the parietal bone at -4.00 mm posterior and 
1.00 mm lateral to bregma; a thermistor (yellow) for the detection of the 
hypothalamic temperature was placed -1.00 mm posterior and 1.00 mm lateral to 
bregma.
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Figure 2. The figure shows a schematic illustration of the surgical implantation 
of the catheter for telemetric measurement of arterial pressure in the femoral 
artery (A) and the electrodes for recording of diaphragmatic electromyogram (B).
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Figure 3. The weight of rats kept for 8 weeks under either a normocaloric (NC, 
n=7) or a hypercaloric (HC, n=8) diet is shown. * NC vs. HC, p<0.05
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Figure 4. The relative amount (mean ± S.E.M.) of Wake, NREM sleep (NREMS) 
or REM sleep (REMS) during a 24-h period in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet is shown. Amount is expressed as 
the percent of the 24-h period. Data represent the average of two consecutive days 
of baseline recording. * NC vs. HC, p<0.05.
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Figure 5. The relative amount (mean ± S.E.M.) of Wake, NREM sleep or REM 
sleep during either the Light (L) or the Dark (D) period of the normal 12h:12h 
LD cycle in rats kept under either a normocaloric (NC) or a hypercaloric (HC) 
diet is shown. Amount is expressed as the percent of the 12-h period. Data 
represent the average of two consecutive days of baseline recording. * NC vs. HC, 
p<0.05. C L vs. D, p<0.05.
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Figure 6. The relative amount (mean ± S.E.M.) of Single REM sleep or 
Sequential REMS sleep during either the Light (L) or the Dark (D) period of the 
normal 12h:12h LD cycle in rats kept under either a normocaloric (NC) or a 
hypercaloric (HC) diet is shown. Amount is expressed as the percent of the 12-h
period. Data represent the average of two consecutive days of baseline recording. 
* NC vs. HC, p<0.05. C L vs. D, p<0.05.
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Figure 7. The number (No., mean ± S.E.M.) of Single REM sleep episodes or 
Sequential REMS sleep episodes during either the Light (L) or the Dark (D) 
period of the normal 12h:12h LD cycle in rats kept under either a normocaloric 
(NC) or a hypercaloric (HC) diet is shown. Data represent the average of two 
consecutive days of baseline recording. * NC vs. HC, p<0.05. C L vs. D, p<0.05.
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Figure 8. The average duration (s, mean ± S.E.M.) of Single REM sleep episodes 
or Sequential REMS sleep episodes during either the Light (L) or the Dark (D) 
period of the normal 12h:12h LD cycle in rats kept under either a normocaloric 
(NC) or a hypercaloric (HC) diet is shown. Data represent the average of two 
consecutive days of baseline recording. * NC vs. HC, p<0.05. C L vs. D, p<0.05.
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Figure 9. The average hypothalamic temperature (°C), mean arterial blood 
pressure (mmHg) and heart rate levels (bpm) (mean ± S.E.M.) during a 24-h 
period in rats kept under either a normocaloric (NC) or a hypercaloric (HC) diet 
are shown. Data represent the average of two consecutive days of baseline 
recording. * NC vs. HC, p<0.05.
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Figure 10. The average hypothalamic temperature (°C), mean arterial blood 
pressure (mmHg) and heart rate levels (bpm) (mean ± S.E.M.) in either Wake, 
NREM sleep (NREMS), or REM sleep (REMS), during a 24-h period in rats kept 
under either a normocaloric (NC) or a hypercaloric (HC) diet are shown. Data 
represent the average of two consecutive days of baseline recording. * NC vs. HC, 
p<0.05.
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Figure 11. The average hypothalamic temperature levels (°C, mean ± S.E.M.) 
during either the Light (L) or the Dark (D) period of the normal 12h:12h LD cycle
in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet are shown. Data represent the 
average of two consecutive days of baseline recording. * NC vs. HC, p<0.05. C L 
vs. D, p<0.05.
110
Systolic arterial blood pressure - Wake - 12h
80
90
100
110
120
130
NC HC
m
m
H
g
L
DC*
*
Systolic arterial blood pressure - NREM sleep - 12h
80
90
100
110
120
130
NC HC
m
m
H
g
L
DC*
*
Systolic arterial blood pressure - REM sleep - 12h
80
90
100
110
120
130
NC HC
m
m
H
g
L
D**
111
Figure 12. The average systolic arterial blood pressure levels (mmHg, mean ± 
S.E.M.) during either the Light (L) or the Dark (D) period of the normal 12h:12h 
LD cycle in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet is shown. Data represent the 
average of two consecutive days of baseline recording. * NC vs. HC, p<0.05. C L 
vs. D, p<0.05.
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Figure 13. The average diastolic arterial blood pressure levels (mmHg, mean ± 
S.E.M.) during either the Light (L) or the Dark (D) period of the normal 12h:12h 
LD cycle in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet is shown. Data represent the 
average of two consecutive days of baseline recording. * NC vs. HC, p<0.05. C L 
vs. D, p<0.05
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Figure 14. The average mean arterial blood pressure levels (mmHg, mean ± 
S.E.M.) during either the Light (L) or the Dark (D) period of the normal 12h:12h 
LD cycle in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet is shown. Data represent the 
average of two consecutive days of baseline recording. * NC vs. HC, p<0.05. C L 
vs. D, p<0.05.
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Figure 15. The average heart rate levels (bpm, mean ± S.E.M.) during either the 
Light (L) or the Dark (D) period of the normal 12h:12h LD cycle in either Wake, 
NREM sleep, or REM sleep, in rats kept under either a normocaloric (NC) or a 
hypercaloric (HC) diet is shown. Data represent the average of two consecutive 
days of baseline recording. * NC vs. HC, p<0.05. C L vs. D, p<0. 05
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Figure 16. The relative amount (mean ± S.E.M.) of Wake, NREM sleep or REM 
sleep during either the Light (L) or the Dark (D) period of the normal 12h:12h LD 
cycle in rats kept under either a normocaloric (NC) or a hypercaloric (HC) diet is 
shown. Amount is expressed as the percent of the 12-h period. Animals were kept 
under baseline (BL) conditions for two consecutive days. During the third day 
they were totally sleep deprived by gentle handling for 12 hours (SD) and then 
allowed to recover for 12 hours (RD). During the fourth day the recovery was 
completed (R1). Data of the two days of the baseline recording have been 
averaged. * NC vs. HC, p<0.05. C L vs. D, within the same experimental Day,  
p<0.05. § SD, R0, or R1 vs. BL.
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Figure 17. The relative amount (mean ± S.E.M.) Single REM sleep or Sequential 
REM sleep during either the Light (L) or the Dark (D) period of the normal 
12h:12h LD cycle in rats kept under either a normocaloric (NC) or a hypercaloric 
(HC) diet is shown. Amount is expressed as the percent of the 12-h period. 
Animals were kept under baseline (BL) conditions for two consecutive days. 
During the third day they were totally sleep deprived by gentle handling for 12 
hours (SD) and then allowed to recover for 12 hours (RD). During the fourth day 
the recovery was completed (R1). Data of the two days of the baseline recording 
have been averaged. * NC vs. HC, p<0.05. C L vs. D, within the same 
experimental Day,  p<0.05. § SD, R0, or R1 vs. BL.
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Figure 18. The number (mean ± S.E.M.) of Single REM sleep episodes or 
Sequential REM sleep episodes during either the Light (L) or the Dark (D) period 
of the normal 12h:12h LD cycle in rats kept under either a normocaloric (NC) or a 
hypercaloric (HC) diet is shown. Animals were kept under baseline (BL) 
conditions for two consecutive days. During the third day they were totally sleep 
deprived by gentle handling for 12 hours (SD) and then allowed to recover for 12 
hours (RD). During the  fourth day the recovery was completed (R1). Data of the 
two days of the baseline recording have been averaged. * NC vs. HC, p<0.05. C L 
vs. D, within the same experimental Day,  p<0.05. § SD, R0, or R1 vs. BL.
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Figure 19. The average duration (s, mean ± S.E.M.) of Single REM sleep 
episodes or Sequential REM sleep episodes during either the Light (L) or the Dark 
(D) period of the normal 12h:12h LD cycle in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet is shown. Animals were kept 
under baseline (BL) conditions for two consecutive days. During the third day 
they were totally sleep deprived by gentle handling for 12 hours (SD) and then 
allowed to recover for 12 hours (RD). During the fourth day the recovery was 
completed (R1). Data of the two days of the baseline recording have been 
averaged. * NC vs. HC, p<0.05. C L vs. D, within the same experimental Day,  
p<0.05. § SD, R0, or R1 vs. BL.
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Figure 20. The relative cumulative amount of NREM sleep (mean ± S.E.M.) in 
rats kept under either a normocaloric (NC) or a hypercaloric (HC) diet is shown 
with a 12-h resolution, according to the normal 12h:12h Light-Dark (LD) cycle. 
Data are expressed as the percent of the baseline levels (baseline=100%). Animals 
were kept under baseline (BL_L, BL_D) conditions for two consecutive days. 
During the third day they were totally sleep deprived by gentle handling for 12 
hours (SD_L) and then allowed to recover for 12 hours (R0_D). During the fourth
day the recovery was completed (R1_L, R1_D). Data relative to the two days of 
the baseline recording have been averaged. 
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Figure 21. The relative cumulative amount of REM sleep (mean ± S.E.M.) in rats 
kept under either a normocaloric (NC) or a hypercaloric (HC) diet is shown with a 
12-h resolution according to the normal 12h:12h Light-Dark (LD) cycle. Data are 
expressed as the percent of the baseline levels (baseline=100%). Animals were 
kept under baseline (BL_L, BL_D) conditions for two consecutive days. During 
the third day they were totally sleep deprived by gentle handling for 12 hours 
(SD_L) and then allowed to recover for 12 hours (R0_D). During the fourth day 
the recovery was completed (R1_L, R1_D). Data relative to the two days of the 
baseline recording have been averaged.
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Figure 22. The time course of Delta (0.5-4.0 Hz) and Sigma (11.0- 15.0 Hz) 
Power during NREM sleep in rats kept under either a normocaloric (NC) or a 
hypercaloric (HC) diet is shown. Data expressed as the percent of the average 24-
h baseline levels and are shown with a 2-h resolution. Animals were kept under 
baseline (BL) conditions for two consecutive days. During the third day they were 
totally sleep deprived by gentle handling for 12 hours (SD) and then allowed to 
recover for 12 hours (RD). During the fourth day the recovery was completed 
(R1). Data of the two days of the baseline recording have been averaged. @ SD, 
RD, or R1 vs. BL, for NC. § SD, RD, or R1 vs. BL, for HC.
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Figure 23. The time course of Theta (5.5-9.0 Hz) Power during REM sleep in rats 
kept under either a normocaloric (NC) or a hypercaloric (HC) diet is shown. Data 
are expressed as the percent of the average 24-h baseline levels and are shown 
with a 2-h resolution. Animals were kept under baseline (BL) conditions for two 
consecutive days. During the third day they were totally sleep deprived by gentle 
handling for 12 hours (SD) and then allowed to recover for 12 hours (RD). During 
the fourth day the recovery was completed (R1). Data of the two days of the 
baseline recording have been averaged.
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Figure 24. The average hypothalamic temperature levels (°C, mean ± S.E.M.) 
during either the Light (L) or the Dark (D) period of the normal 12h:12h LD cycle 
in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet are shown. Animals were kept 
under baseline (BL) conditions for two consecutive days. During the third day 
they were totally sleep deprived by gentle handling for 12 hours (SD) and then 
allowed to recover for 12 hours (RD). During the fourth day the recovery was 
completed (R1). Data of the two days of the baseline recording have been 
averaged. * NC vs. HC, p<0.05. C L vs. D, within the same experimental Day,  
p<0.05. § SD, RD, or R1 vs. BL.
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Figure 25. The average mean arterial blood pressure levels (mmHG, mean ± 
S.E.M.) during either the Light (L) or the Dark (D) period of the normal 12h:12h 
LD cycle in either Wake, NREM sleep, or REM sleep, in rats kept under either a 
normocaloric (NC) or a hypercaloric (HC) diet are shown. Animals were kept 
under baseline (BL) conditions for two consecutive days. During the third day 
they were totally sleep deprived by gentle handling for 12 hours (SD) and then 
allowed to recover for 12 hours (RD). During the fourth day the recovery was 
completed (R1). Data of the two days of the baseline recording have been 
averaged. * NC vs. HC, p<0.05. C L vs. D, within the same experimental Day,  
p<0.05. § SD, RD, or R1 vs. BL.
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6. Discussion
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Figure 26. The average heart rate levels (bpm, mean ± S.E.M.) during either a the 
Light (L) or the Dark (D) period of the normal 12h:12h LD cycle in either Wake, 
NREM sleep, or REM sleep, in rats kept under either a normocaloric (NC) or a 
hypercaloric (HC) diet are shown. Animals were kept under baseline (BL) 
conditions for two consecutive days. During the third day they were totally sleep 
deprived by gentle handling for 12 hours (SD) and then allowed to recover for 12 
hours (RD). During the fourth day the recovery was completed (R1). Data of the 
two days of the baseline recording have been averaged. * NC vs. HC, p<0.05. C L 
vs. D, within the same experimental Day,  p<0.05. § SD, RD, or R1 vs. BL.
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